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Abstract
Existing research suggests that a variety of environmental factors play an
important role in cancer mortality. The association between some of these factors and
cancer mortality was examined using data from the Charleston Heart Study, a thirty-five
year prospective cohort. Baseline measurements for tobacco use, place of residence,
occupation, education, water supply and physical activity were made in 1960/63 on 2,283
participants. The vital status of the cohort was ascertained through 1994, and the
underlying cause of death as determined by the nosologist was used to define cancer
mortality. There were 294 cancer deaths identified over the 35-year period. Statistical
analyses showed cigarette smoking and occupational history to be significant predictors
for cancer mortality. In 1974/75 self reported information on pesticide and DDT use
were collected and serum DDE levels were measured on 898 participants from the
original cohort. There were 108 cancer deaths identified in the 20-year period between
1974 and 1994. There was no difference in cancer mortality rates between those who
reported pesticide use and those who did not. The mean serum level ofDDE for those
dying of cancer was significantly less than the level observed in the remaining cohort
(33.5 ppb vs. 37.2 ppb, p < 0.05). Analyses using proportional hazards regression models
suggested no increase in the risk of cancer mortality associated with higher levels of
DDE. The incidence of breast and prostate cancer was also evaluated using a nested casecontrol design. There were 21 new breast cancers and 28 new prostate cancers identified

..
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in the 20-year period. The mean serum level ofDDE for those with breast or prostate
cancer was significantly less than the level of their matched controls (26.7 vs 35.1; 33.8
vs 41.4 ppb, p<O.05). Results from conditional logistic regression models suggested no
increase in either breast or prostate cancer risk associated with increasing levels ofDDE.
In summary, there was no evidence to support an increased risk of breast cancer incidence
for women, an increased risk of prostate cancer incidence for men, or an increased risk of
cancer mortality for all subjects associated with DDE.

I. Introduction
Incidence rates for cancer have increased for all race and sex groups (Ries et aI.,
1994). For more than a decade, there has been general agreement that most cancer results
from man-made and natural environmental exposures acting in concert with genetic and
acquired characteristics (Perera, 1996). Exposure to environmental pollutants is nearly
unavoidable. Some of the environmental factors suggested to be associated with cancer
mortality and morbidity include tobacco use, pollution, diet, exposure to various manmade chemicals including pesticides, viruses and socioeconomic factors, such as
occupation, place of residence and educational attainment. It has been estimated that
without these environmental factors, cancer incidence would be reduced by as much as
80 to 90% (Higginson & Muir, 1976; Weinstein et al., 1995).
Cigarette smoking has been purported to be the single most preventable cause of
excess mortality in the U.S. It contributes as many as 25% to 40% of all cancer deaths
(Ruddon, 1995). The effect of general pollutants in the air and water have been estimated
to cause one to five percent of all cancer deaths (Doll & Peto, 1981). Occupational
studies have played a sigrJficant role in identifying carcinogenic and possible
carcinogenic agents such as metals, solvents, polymers and pesticides (IARC, 1987). For
many decades differences in cancer incidence and mortality have been observed between
urban and rural communities, with the risk of cancer mortality higher in urban dwellers
(Doll, 1991). Educational level, a social status indicator, has been shown to be directly
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and indirectly related to several types of cancer (Faggiano et a!., 1995). Higher levels of
physical activity have also been suggested to reduce the overall incidence of cancer
(Shephard, 1995).
Environmental contaminants such as pesticides have been implicated in some
investigations. The intensive use of persistent organochlorine chemicals, both in
agriculture and industry, has led to widespread contamination of the environment, and
residues are found at every level of the food chain (Hayes, 1975). High levels of these
compounds have been found in human adipose tissue, serum and milk. Although many
industrial countries have restricted or banned the use of various organochlorine
chemicals, significant amounts of these pesticides are still being used in many developing
countries (Kashyap et aI., 1993).
One particular organochlorine that has been the subject of considerable research is
dichloro-diphenyltrichloroethane (DDT). This lipophilic compound has a long half-life
and thus is metabolized very slowly by humans, so that DDT metabolites, including
DDE, are detectable in the fat and sera of people long after exposure has ended. The
widespread agricultural use of DDT in the US began in 1945. In June 1972, the
Environmental Protection Agency (EPA) banned all crop uses of DDT primarily because
amounts were building up in the environment and because some carcinogenic tests in
laboratory animals showed positive results (Clement, 1989). Despite a public health
interest, relatively few epidemiological studies on the possible DDT-cancer association
have been completed and they have provided inconsistent results.
The Charleston Heart Study provided the opportunity to examine some of these
putative cancer risk factors in an ethnically diverse population with a long term follow-
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up. The epidemiological study was designed to focus on a variety of environmental
factors as recorded at the initial examination of the Charleston Heart Study cohort in
order to identify potential predictors for cancer incidence and to contribute further
understanding of the possible link between DDT and cancer. The cohort also provided
the opportunity to assess the utility of self-reported pesticide exposure with risk of
cancer.

Specific Aims
The goal of the study was to quantify the association of putative environmental
risk factors with cancer morbidity and mortality in a population based cohort. The study
was designed to test the hypothesis that serum DDE level is a risk factor for cancer,
specifically breast and prostate cancer. Additional exploratory analysis focused on a
variety of environmental factors to identify potential risk factors for cancer mortality.
Using data collected as part of the ongoing Charleston Heart Study, the specific
alms were:
1.

To describe the cancer mortality patterns with reference to environmental
factors collected at the 1960 baseline or 1963 re-examination, including
a. place of residence
b. occupation
c. educational attainment
d. source of water supply
e. physical activity level, and
f. tobacco use;

2.

To quantify the association between pesticide exposure and cancer mortality
USIng:
a. self-reported use' of pesticides
b. serum DDE levels
and to compare the utility of self-reported data;

3.

To test the hypothesis that an increased risk of breast and prostate cancer are
associated with high levels ofDDE.

II. Background and Significance
Cancer Incidence
Cancer of some form strikes more than one third of the population, accounts for
more than 20 percent of all deaths, and in developed countries is responsible for more
than 10 percent of the total cost of medical care. Over one million new cases are
identified each year in the United States and approximately 500,000 people die (Ruddon,
1995). Over the past few decades incidence rates for all types of cancer combined have
increased in the U.S. For the time period 1973-1991, there was a 31 percent increase in
cancer among white men, a 15 percent increase among white women, a 34 percent
increase among black men and an 18 percent increase among black women (Ries et aI.,
1994). Overall cancer incidence (1987-91) was highest among black men (557.2 per
100,000) followed by white men (464.0), white women (348.0) and black women (331.8)
(Ries et al., 1994). The largest increase in cancer incidence has been observed in the
older population, those aged 65 and older. This segment of the population has rates that
increased over 30 percent between 1973 and 1991(Ries et al., 1994).
Although the overall cancer incidence has increased, there are differences in rates
associated with various specific cancers. The rates also vary somewhat by ethnicity.
Since the mid-1980s, lung cancer incidence rates have reached a plateau while prostate
cancer has continued to increase. For both black and white men, the prostate gland is the
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most common site of cancer, followed by lung cancer as the second most common site,
and colorectal cancer as the third most common site. Bladder cancer is the fourth most
commonly diagnosed cancer in white men, but ranks only ninth for black men (Harras et
aI., 1996).
For both black and white women, breast cancer is the most common site of
occurrence. Lung cancer is the second most frequently occurring type followed by
colorectal for white women; colorectal is the second highest for black women and lung
cancer ranks as third. The fourth most common site for both black and white women is
corpus uteri (Harras et aI., 1996).
Not only are there differences in rates across race-sex groups, there is also a
variation worldwide. For men, the recent overall cancer incidence rates ranged from
493.8 per 100,000 in Australia, to a low of 59. 1 in The Gambia (Parkin et al., 1992).
Incidence rates for U.S. men are 351.1 for blacks and 330.4 for whites (Ries et aI., 1994).
For women, the overall incidence rates ranged from a high of345.4 per 100,000
in British Columbia, Canada to a low of39.6 in The Gambia (Parkin et al., 1992). The
comparable rate for u.S. white women is 277.0 and the rate for black women is 227.1 per
100,000 (Ries et aI., 1994).

Cancer Mortality
From 1973 to 1991, the overall cancer mortality rates have increased between
seven and eight percent (Ries et al., 1994). The number one cause of cancer death in the

u.s. is cancer of the lung and bronchus.

Lung cancer is the number one cause of death

for white men and women as well as for black men. Among black women, breast cancer
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mortality rates are slightly higher than the rates for lung cancer. For both white and black
men, prostate cancer is the second most common cause of cancer death followed by
colorectal cancer. For both white and black women, the three most common sites for
mortality are lung, breast and colon cancer. As noted earlier, breast cancer mortality is
slightly higher for black women than for white women; however, if lung cancer trends
continue upward, it is expected that lung cancer mortality will surpass breast cancer
mortality for black women as it has done for white women (Harras et al., 1996).
As with cancer incidence, there seems to be a dual impact of cancer mortality on
older people. Not only are mortality rates much higher in the older groups, they are also
increasing (Harras et al., 1996). There has been more than 14 percent increase in the
mortality rates in those over 65 years of age from the time period of 1973 to 1991 (Ries et
aI., 1994).
Examination of the death rates for all cancer sites combined provide evidence of
the variation in cancer by country and sex. For men, there is a four-fold difference
between the countries with the lowest (54.4 per 100,000 in Thailand) and the highest
(235.4 in Hungary) cancer mortality rates. The difference in women is almost four fold,
with the lowest (36.4) occurring in Thailand and the highest (139.4) occurring in
Denmark (Parkin et aI., 1992). Compared with 50 countries, U.S. men rank 24th (163.2
per 100,000) and women rank 17th (109.7 per 100,000) in regards to mortality rates (Ries
et aI., 1994).
Comparison of specific c"ancer mortality rates show that U.s. men rank 12th in
lung cancer mortality and females rank fourth. Belgium has the highest lung cancer
mortality rate for males; Scotland has the second highest rate for men and the highest for
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women (Parkin et al., 1992). Within the U.S. there is geographical variation among lung
cancer deaths; men in the South have the highest mortality rates while females on the
West coast have the highest rates (Ries et aI., 1994).

Breast Cancer

Incidence
Breast cancer is the most commonly occurring cancer among both white and black
women. In 1994, there were approximately 182,000 new cases of breast cancers and
46,000 deaths from the disease (Kosary et aI., 1995). Examination of incidence rates
reveals a significant increase in 1974. This increase may have been due to an increased
awareness for screening since the rates subsequently fell. However, in the period of 1980
to 1987, the rate increased from 85.2 per 100,000 to 112.4, and then leveled off. These
increases have been observed in both younger and older white and black women (Kosary
et aI., 1995).
Considerable variation in incidence rates occurs among major racial/ethnic groups
in the US. Above 40 to 45 years of age, white women have the highest rates, followed by
black women. At younger ages, black women have slightly higher rates than white
women (Kelsey & Honl-Ross, 1993).

Possible Etiologic Pathways
The etiology of breast cancer is not completely understood and is undoubtedly
complex. Presence of the breast cancer gene, BRCA1, accounts for less than five percent
of cases. Genetic inheritance and all other characteristics, or risk factors, known to
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increase susceptibility explain only about a third of all cases (Davis & Bradlow, 1995).
Existing evidence strongly indicates the importance of ovarian hormones in the
pathogenesis of breast cancer (Henderson & Bernstein, 1996). One feature that is
common to the known risk factors for breast cancer is an elevated total lifetime exposure
to estrogen (Kelsey & Hom-Ross, 1993). Table 1 lists some of the characteristics
associated with increased and decreased levels of estrogen.

Table 1
Factors Associated with Estrogen Levels
Factors which lead to increased exposure to estrogen

Early menarche
Late menopause
Obesity (postmenopausal women)
Hormone replacement therapy
Factors which lead to a decreased exposure to estrogen

Early first-term pregnancy
Lactation
Physical activity

It is believed that ovarian hormones are not genotoxic but affect the rate of cell
division, thus increasing the risk of breast cancer by accelerating mitotic activity of the
breast epithelial cell (Henderson & Bernstein, 1996). Recent advances in the molecular
biology of cancer have provided a basis for the concept that cell division is essential in
the genesis of human cancer (Henderson & Bernstein, 1996). This "out of control"
~

division is believed to require the accumulation of mutations in genes that regulate cell
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division and ensure the accurate replication of DNA. Hormones and other substances
around the cell can also prompt abnormal cell growth (Davis & Bradlow, 1995).
Estrogens, in particular 17

~-estradiol,

have the ability to induce replication of

epithelial cells in mammary tissue (Jordan, 1986). This hormone influences cell growth
by binding to an intracellular protein known as the estrogen receptor. Complexes of
hormone and receptor bind to DNA in the nucleus and activate certain genes that enhance
cell division. Enhanced cell replicating and by inference DNA replication, increases the
probability that a potentially carcinogenic mutation will occur and go unrepaired (Jordan,
1986).
The metabolic fate of estradiol in humans is largely determined by the relative
activities of two cytochrome P450-dependent enzymes that hydroxylate the parent
estrogen at either the C-16a or the C-2 position (See diagram Figure 1). Several studies
have demonstrated a marked difference in the estrogenic activity of 2-hydroxylated and
16a-hydroxylated estrogens. The 2-hydroxylated products possess little estrogenic
activity. In contrast, the 16a-hydroxylated product binds extensively and irreversibly to
the estrogen receptor in cell culture studies (Michnovicz & Bradlow, 1990).
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Figure 1
Metabolism of Estradiol to 160.- or 2- Hydroxyestrone

CH

CH

It is suspected that increased production of 16-alpha hydroxyestrone increases the
risk of breast cancer. The 2-hydroxyestrone only weakly activates the estrogen receptor;
while the 16-alpha metabolite strongly increases the interaction of the estrogen receptor
with growth promoting genes and possibly enhances breast cell proliferation (Davis &
Bradlow, 1995; Bradlow et al., 1986). Evidence for this has been demonstrated in animal
studies and also in recent human trials that have linked elevated levels of 16-alpha
hydroxyestrone to breast cancer (Martucci & Fishman, 1993).

11
Prostate Cancer

Incidence
In the mid-1980s there was a shift in the ordering of the most frequent types of
cancer. There was an increase in prostate cancer and a leveling off of lung cancer
incidence rates which resulted in prostate cancer becoming the number one cancer among
men (Harras et aI., 1996). The number of prostate cancers has continued to increase. In
1994, there were approximately 240,000 new cases of prostate cancer with 40,000 deaths
(Ries et al., 1994).
It has been shown that the survival of men with untreated first stage prostate
tumor is similar to that of men who are disease free and of the same age. This finding is
not surprising considering autopsy studies have shown that 20% of 60-year old men have
microscopic foci of prostate cancer (Byrne et aI., 1996). More than 750/0 of patients with
prostate cancer survive at least 5 years after diagnosis (NCI, 1992). There is a racial
difference in survival with white men having an advantage (Ries et aI., 1994). The lower
survival in black men may reflect differences in stage at diagnosis, but other risk factors
may also playa role in the racial disparity.
The international pattern of prostate cancer ranges from low rates in Asian
countries to the highest rates in North European and American countries. More that 80%
of cases of prostate cancer are diagnosed in men older than 65, and black men have the
highest incidence in the world (Greco & Kulawiak, 1992).
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Possible Etiologic Pathways
Apart from the nine percent of men with hereditary prostate cancer, the strongest
risk factor for the development of prostate cancer known to date is age (Carter et aI.,
1992). Existing evidence strongly indicates the importance of endocrine function in the
etiology of prostate cancer. Circulating androgens are essential for the growth of the
normal prostate gland and for the development of benign prostatic hyperplasia and
prostate cancer change. Although the precise role of androgens in terms of carcinogenesis
is unclear, however they seem to act by promoting cell growth and division (Taplin et al.,
1995).
Testosterone is metabolized within the prostate to dihydrotestosterone (DHT) by
the enzyme 5-alpha reductase. DHT is the major intracellular androgen that promotes
growth within the prostate (Bruchovsky & Wilson, 1968). About 90 percent of the
testosterone which diffuses into the prostate is converted to DHT (Coffey, 1979). The
precise role ofDHT in the promotion of prostate cancer is unclear. However, prostate
cancer has been shown to be absent in pseudohermaphrodite men in whom 5-alpha
reductase is absent (Kirby et aI., 1996). It is possible that the geographical variation of
prostate cancer might be related in some way to different levels of DHT in ethnic groups.
In particular, a reduced activity of 5-alpha reductase has been reported in Japanese men;
this could account for the lower, but rising, prevalence of prostate cancer in Japan (Ross
et al., 1992). A number of studies comparing circulating testosterone levels in men with
prostate cancer to controls of similar age with no known prostate disease have provided
inconsistent evidence (Ross & Schottenfeld, 1996).
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The exact role of estrogens in the prostate remains unknown, although it has been
suggested that they synergistically promote biological effects of androgens (Griffiths &
Khoury, 1994). Recent research indicates an important role of several growth factors
which have been derived from the prostate in the pathogenesis of prostate cancer (Calais
de Silva, 1994). Despite major understanding of the endocrine and biochemical processes
in regulating prostatic growth, there is no consistent evidence of one primary endocrine
disturbance that is implicated in the genesis of all prostate cancers (Griffiths & Khoury,
1994).

Selected Environmental Risk Factors and Cancer
For the purpose of this study, the term environment includes the measured
characteristics that are not considered to be genetically determined. Cancer risk may be
influenced by many factors, including both environmental factors and genetics. Genetic
predisposition acting in isolation probably explains no more than 5% of all cancers in the

u.s. (Venitt, 1994).

Some of the environmental factors suggested to be risk factors for

cancer incidence and mortality include tobacco use, alcohol consumption, diet,
occupation, pollution, selected consumer products, exposure to medical drugs, sexual
development, reproductive patterns and sexual practices, radiation, infection and other or
unknown associations (Westview Press, 1982). It has been suggested that socioeconomic
factors, including educational attainment, residence, occupation, behavioral patterns, and
income contribute to cancer mortality (Schrijvers & Mackenbach, 1994). This study was
~

used to examine the relationship between some of these putative risk variables that were
collected more than 35 years ago with cancer mortality in a community based cohort.
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Tobacco Use
Worldwide an estimated one billion people smoke cigarettes. Other tobacco
practices are also widespread, including the smoking of pipes or cigars (Council on
Scientific Affairs, 1990). Over 2000 chemical compounds have been identified in the
tobacco leaf, and many others are formed during smoking (Dube & Green, 1982). The
cancer risks associated with tobacco use have been extensively investigated. Tobacco
use, particularly in the form of cigarette smoking, is the single most preventable cause of
excess mortality in the U.S. Epidemiologists have attributed as many as 25% to 40% of
all cancer deaths to tobacco use (Ruddon, I 995). Among male cigarette smokers, the risk
of lung cancer is more than 20 times higher than among male nonsmokers; for women,
the risks are approximately 12 times greater (Shopland, 1996).
It has been suggested that cigarette smoking does not substantially affect the risk
of breast cancer in women (Wald & Baron, 1990; Palmer & Rosenberg, 1993). Smoking
produces an anti-estrogen effect, increasing the risk of several estrogen-related diseases
including osteoporotic fractures and endometrial cancer (Baron, 1984). Data do not
suggest any differences in circulating estrogen levels in postmenopausal smokers
compared to nonsmokers (Barrett-Conner & Khaw, 1990). Separate analysis of breast
cancer in premenopausal and postmenopausal women do not revealed an effect of
smoking in either group, as neither have investigations of estrogen receptor positive or
negative tumors (Palmer & Rosenberg, 1993). Additionally researchers report that
cigarette smoking is not associated with the proliferative breast lesions which are strongly
linked with breast cancer (Rohan et aI., 1989).
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Most investigations of prostate cancer and cigarette smoking have reported no
association (Cederlof et aI., 1975; Doll & Peto, 1976; Garfinkel, 1980; Hirayama, 1990;
Talamini et aI., 1993). However, there have been some which have noted increased risks,
particularly among heavy smokers (Honda et aI., 1988; Hsing et al., 1991; Hiatt et aI.,
1994). Circulating testosterone levels have been found to be higher in cigarette smokers
than in nonsmokers; although the differences were not large and not dose related (Dai et
al., 1981; Deslypere & Vermeullen, 1984; Barrett-Conner & Khaw, 1990).

Water Sources
Although the quality of drinking water in industrialized nations is looked upon as
the best in the world, there is growing concern that various contaminants may contribute
to the burden of environmental carcinogenesis (Cantor et aI., 1996). Drinking water
contains complex mixtures of known and suspected carcinogens, including asbestos,
metals, radioactive substances and industrial chemicals (Cantor, 1990). Water pollution
can occur through chlorination, from by products of manufacturing facilities, agriculture,
logging sites, mining facilities, power generators, and hazardous waste disposal sites
(Swanson, 1988). There is no evidence to indicate an increased or decreased risk of
breast or prostate cancer with the quality or source of drinking water.

Occupation
Studies of occupational groups have played a key role in identifying potential
causes of human cancer. Occupational studies have been particularly useful because they
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are comprised of defined popUlations on whom exposures can be monitored and
identified.
The first recognized cancer associated with occupational exposure was identified
by Percival Pott, a British surgeon who observed that scrotal cancer occurred more
frequently in men who had been employed as chimney sweeps during their boyhood.
This observation led to the identification of soot components as the first chemical and
occupational carcinogens (Westview Press, 1982). Since then many other groups of
workers have been found to experience cancer resulting from occupational exposure. The
agents which have been identified as either carcinogenic or probably carcinogenic to
humans include metals, solvents, organic and inorganic dust, chemicals used to construct
polymers, and pesticides (IARC, 1987). Appendix A contains a list of occupational
groups which have experienced an excess risk of cancer (Monson, 1996). From this list it
is apparent that lung cancer was the type of cancer most often associated with an excess
risk for the various occupation groups.
The relationship of occupational exposures in women has only recently been
investigated. Several studies have shown high rates of breast cancer in school teachers
and nurses, probably owing to their higher socioeconomic status and reproductive
histories, such as older age at first pregnancy (Brinton & Devesa, 1996). A recent
conference on occupational risks among women suggested possible breast cancer links
with employment in the printing and publishing, telephone, and electrical equipment
manufacturing industries (Pottern et al., 1994).
Cadmium has been the focus of many occupational studies concerning prostate
cancer. Cadmium, a non-essential trace element, is a zinc antagonist in biological
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systems (Gunn et aI., 1961). Because zinc is involved in the regulation of cell growth and
is concentrated heavily in prostatic tissue, it has been suspected that accumulation of
cadmium in the prostate might interrupt normal cell growth and result in cancer (Kolonel
& Winkelstein, 1977). Early epidemiological studies provided some limited support for

this hypothesis (Kipling & Waterhouse, 1967; Kolonel & Winkelstein, 1977). Other
studies have been unable to confirm any association between prostate cancer risk and
cadmium exposure (Armstrong & Kazantzis, 1985).
Several investigators have suggested that farmers are at a higher risk of prostate
cancer. Blair and Zahm reviewed 24 occupational cohort studies and surveys to
determine if there was evidence of an association between prostate cancer and pesticide
exposure. They found that ten of the 24 studies had a significant elevated risk while only
one reported a significant lower risk. The range of the relative risks for all twenty-four
studies was 0.9-2.0 (Blair & Zahm, 1991).

Residence
Differences in cancer incidence have been observed between urban and rural
communities for many decades (Clemmesen, 1969; Bako et al., 1984; Muir et al., 1987;
Doll, 1991; Nasca et at, 1992; Friis & Storm, 1993; Howe et al., 1993). In general the
risk of cancer has been higher in urban populations. The excess risk in urban
communities was greatest for cancers of the bladder, larynx, liver, lung, mouth and
pharynx, and esophagus. Differences in personal behavior (tobacco and alcohol use,
sexual promiscuity, exposure to ultraviolet (UV) light, type of diet and family size) have
been hypothesized as the principal factors responsible for the excess risk among urban
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residents. A rural excess for cancer of the lip has been observed (Doll, 1991). Cancer of
the lip and non-melanoma skin cancer are thought to be caused by exposure to UV light;
people in rural areas are more likely to be exposed to UV radiation because of their
greater likelihood of working out of doors (Schouten et aI., 1996).
It has been shown that residency in urban areas is associated with an increased
risk of breast cancer (Brinton & Devesa, 1996). This may be explained because breast
cancer generally occurs more often among women of the upper social classes. It has been
suggested that socioeconomic, reproductive and dietary factors which are all associated
with the place of residency, may playa role in breast cancer (Jacobsen & Lund, 1990).
Prostate cancer has been shown to be less likely to develop in men living in a rural
environment than in their counterparts living within urban areas. Futhermore urban
residents have also been at greater risk of dying from the disease (Blair & Fraumeni,
1978). The factors responsible for the difference in residence could be possibly attributed
to general environmental pollution by chemical agents, as well as exposure to substances
within the work place (Kirby et al., 1996).

Education
The distribution of cancer within society is complex but is associated with a set of
risk factors (occupation, diet, personal habits) whose prevalence is a function of the social
stratification of a society. Educational level has been used as a social status indicator in
several studies of cancer mortality (Faggiano et al., 1995). Numerous studies have
confirmed an inverse relationship between cervical cancer and education (Faggiano et al.,
1995; Corral et al., 1996). Other cancers shown to be associated with educational level
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include colon, pancreas and bladder (Faggiano et al., 1995; Vizcaino et aI., 1994). In
each case there was an inverse relationship between educational level and cancer risk.
There has been a direct relationship observed between breast cancer and
educational status (Jacobsen & Lund, 1990). Breast cancer is a disease that has been
shown to occur more often among women of the upper social classes, as measured by
either educational status or family income (Krieger, 1990). This association largely
reflects the effect of correlated life-style factors, such as later ages at first birth (Jacobsen
& Lund, 1990).
No clear relationship has been observed between the risk of prostate cancer and
educational attainment. The possible relationship between socioeconomic characteristics
and prostate cancer has been examined in a variety of ways, including occupational data
obtained from death certificates, family income and educational level. These studies
reported no large differences in prostate cancer risk between men in the highest compared
to those in the lowest strata, no matter how socioeconomic status was defined (Seidman,
1970; Ernster et al., 1977; Baquet et al., 1991).

Physical Activity
A growing number of well controlled studies have suggested that both hard
physical work and an active leisure lifestyle reduce the overall incidence of cancer
(Shephard, 1995). A recent study suggested exercise may help prevent certain cancers
(Mackinnon, 1994). Colon cancer has been suggested as the most prevalent cancer that
could be reduced by physical activity (Giovannucci et aI., 1995).
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Little attention has focused on the role of physical activity and breast cancer even
with the growing concern of the effects of body size and dietary factors on breast cancer
risk. One study found reductions in risk of early-onset breast cancer associated with
regular physical activity, independent of body size (Bernstein et al., 1994). This
relationship seemed plausible because physical activity can modify menstrual cycle
patterns and alter the production of ovarian hormones (Brinton & Devesa, 1996).
However other studies have failed to find an association of breast cancer risk and physical
activity (Dorgan et aI., 1994; Paffenbarger et aI., 1987).
The relationship between physical activity and prostate cancer is unclear. There is
some evidence that physical activity is associated with other prostate cancer risk factors.
Recent investigations have suggested decreased regular physical activity is associated

with increased endogenous circulating testosterone levels, increased fat distribution, and
body mass index (Thune & Lund, 1994). However previous studies reported conflicting
conclusions about whether decreased recreational and occupational physical activity was
an independent risk for prostate cancer (Paffenbarger et aI., 1987; Severson et al., 1989;
LeMarchand et aI., 1991; Hsing et al., 1994).

DDT Exposure
DDT (dichlorodiphenyl trichloroethane or 1,1, I-trichloro-2,2-bis(p-chlorophenyl)
ethane) was one of the most popular chemicals used for controlling insects. Technical
DDT is a mixture of three forms: p,p'DDT, o,p'DDT, and o,o'DDT. DDT was fIrst
synthesized in 1874, and its insecticide properties were discovered in 1939. It was used
for controlling insects in agricultural areas and controlling insect borne diseases such as
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malaria. In 1972, the Environmental Protection Agency banned the use of DDT within
the United States because amounts were building up in the environment and carcinogenic
tests in animals showed positive results (Van Ert & Sullivan, 1992).
DDT persists in the environment for long periods of time following its application
to soil and is converted to DDE, which persists even longer. DDT and its primary
metabolites, DDE and DDD, have been found at hazardous waste sites on the National
Priorities List in the US (Van Ert & Sullivan, 1992). DDT is still used in agriculture and
for disease control in other countries, including Mexico, and direct release to the
environment, movement of residues through the environment, and contamination of
imported goods may result in potential low-level exposure to the u.s. population (Van
Ert & Sullivan, 1992). Also, due to the extensive past use of DDT worldwide and its
biological persistence, these materials are virtually Ubiquitous and are continually being
transformed and redistributed in the environment (Clement, 1989).
DDT and its metabolites are found in samples of human blood, adipose tissue,
breast milk, umbilical cord blood and placental tissue. DDT and DDE bioaccumulate in
the food chain and human exposure results primarily from ingestion of meat, fish, poultry
and vegetables. Ingested DDT undergoes reductive dechlorination to DDD and DOE,
although the latter at a slower rate, and therefore DDE is usually used as a biomarker for
past exposure to DDT (Van Ert & Sullivan, 1992). DDT and DDE are stored most
readily in adipose tissue and leave the body slowly through excretion in breast milk and
urine. It has been shown that adipose tissue levels and blood levels of ODE are highly
correlated (Stellman et aI., 1997).
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Animal studies have demonstrated the hormonal properties of DDT. One isomer,
o,p'DDT, possesses estrogenic properties. It has been shown to affect uterotropic activity
and produce an increase in uterine glycogen content in the rat (Bulgar & Kupfer, 1985).
Others have found that p,p'DDE has little ability to bind to the estrogen receptor, but it
inhibits androgen binding to the androgen receptor, androgen induced transcriptional
activity and androgen action in developing, pubertal and adult male rats (Kelce et al.,
1995). These findings in animals suggest that DDT and its metabolites have the capacity
to interact with both the estrogen receptor and androgen receptor, increasing the risk for
hormone-related cancers and reproductive disorders.

Possible Association of Cancer and DDT
Several studies have investigated the possible mechanisms for carcinogenesis
associated with DDT exposure. Inhibition of apoptosis is one possible mechanism
whereby exposure to DDT may suppress the normal process of cell death and thus
promote neoplastic cell division (Wright et aI., 1994). Another avenue may be through
the estrogenic properties of the o,p' isomer. Through binding to the estrogen receptor it
may mimic the action of estradiol, which stimulates cell proliferation and increase the
risk of hormone-related cancers. A third mechanism may involve a system of enzymes,
since DDT is a known inducer of cytochrome P450 enzymes which mediate the
metabolism of estrogen. Studies suggest that DDT may induce the P450 enzyme that
carries out the metabolism of estradiol to 16 alpha-hydroxyestrone which has been shown
to increase the risk of breast cancer (Davis & Bradlow, 1995). A recent investigation
found that DDE has the traits of a potent antiandrogen in rats (Kelce et al., 1995). The
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possible consequences of inhibition of androgen receptor binding and of subsequent
transcriptional activity are similar to the dangers posed by environmental estrogen (Kelce
et aI., 1995).
DDT is classified as an animal carcinogen and evaluated as possibly carcinogenic
to humans by the International Agency of Research for Cancer (IARC, 1987). Appendix
B contains a summary of the epidemiological studies done thus far regarding cancer and
DDT. Most of the literature addressing human carcinogens and pesticides has focused on
occupational exposures. Many of these studies, however, present conflicting results or do
not report on specific chemicals. The few population studies that have been conducted
reported inconsistent results comparing levels of DDT in those with and without cancer.
The purpose of our study was to evaluate the DDT-cancer association previously
reported by other investigators. There have been several small case-control studies thus
far that have investigated the potential effect of an increased risk of breast cancer with
higher levels ofDDE and DDT, and they have reported differing results. Wassennan et
al. examined adipose tissue from 9 women with breast cancer and 5 post-mortem
controls. They found higher p,p'DDE levels in the breast tissue of control patients
compared to malignant tissue in the cases (1976). Unger et al. found no differences in
DDE levels using two different case control studies (1982). The first study compared the
DDE levels in adipose tissue taken at autopsy from 18 women with breast cancer to the
levels in adipose tissue taken at autopsy from 35 women without breast cancer. The
second study included tissue taken from 14 women with breast cancer and from 21
women with other breast abnormalities at the time of surgery. After controlling for age
the investigators found no difference in DDE levels in either study (1984). Mussalo-
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Rauhamaa et aL reported the findings from a case-control study of adipose tissue taken
from 44 women with breast cancer and 33 post-mortem controls. They also found no
differences in p,p'DDT or p,p'DDE levels between the groups (1990). Falck et al.
examined the levels in adipose tissue from 20 women with breast cancer compared to 20
controls with other breast abnormalities and found no significant differences after
adjusting for age, body mass and smoking (1992). More recently, DeWailyet al. have
reported higher DDE levels among 9 breast cancer patients with estrogen receptor
positive tumors when compared to biopsy material from 17 control patients with other
breast abnormalities. There was no difference in DDE levels between the women with
estrogen receptor negative tumors compared to the controls (1994).
Results from several larger epidemiologic studies have been published. Wolff et
a1. reported statistically significant findings from a case-control study of 58 women with
breast cancer and 171 controls (1993). After adjustment for a number of known risk
factors, they found a significant positive association between serum DDE levels and
breast cancer. Given the limited follow-up time of 6 months, it is likely that most of the
breast cancers had occurred prior to enrollment into the cohort, which means breast
cancer was probably present at the time the blood was drawn. This is a potential bias
because the uncertainty of whether the disease came before the exposure is not known. If
organochlorine concentrations are altered because of the disease process, their
conclusions may not be valid.
Krieger et a1. reported on a study of women in the Northern California Region
Kaiser Permanente Medical Care Program, and they concluded that there was no
association between DDE levels measured from frozen sera and subsequent development
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of breast cancer (1994). Serum specimens were obtained from 1964 to 1969 and breast
cancer was ascertained from the time of the examination through 1990. One hundred
fifty cases were randomly selected and compared to an equal number of ethnic and age
matched controls. The levels of serum DDE were higher among black women who
developed cancer than among black women without cancer, while the trend was in the
opposite direction for Asian women, and there was almost no difference between cases
and controls among the white women. Thus far, this was the only other longitudinal
study of DDT and breast cancer using serum collected well before the onset of breast
cancer with over twenty years of follow-up.
A recent study conducted by Hunter et a1. examined participants in the Nurses'
Health Study for an association between DDE and breast cancer. Plasma levels ofDDE
were measured on 236 women who gave a blood sample in 1989 or 1990 and who were
subsequently diagnosed with breast cancer before June 1, 1992. These levels were
compared with those measured in matched control women in whom breast cancer did not
develop. The mulivariate relative risk of breast cancer for women in the highest quintile
of exposure as compared with women in the lowest quintile was 0.72 (CI: 0.37-1.37).
Exposure to high levels of DOE was associated with a nonsignificanly lower risk of
breast cancer (Hunter et al., 1997). The results from this prospective study agreed with
Krieger's et al. findings of no association.
Other researchers concentrated on the risk of postmenopausal breast cancers. A
study of 154 incident postmenopausal breast cancer cases and 192 postmenopausal
community controls showed no association of serum levels ofDDE and breast cancer.
(OR = 1.49; 0.73-3.04) (Moysich et aI., 1997).
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The epidemiological investigations that have been completed thus far have not
been able to examine a direct relationship between prostate cancer and DDT levels, but
they have examined a cohort of individuals occupationally exposed to various pesticides
(Blair,1991). These studies have shown that farmers have an increased risk for prostate
cancer. These tumors, present at higher rates in farmers, are also increasing in the general
population. These studies suggest that the relationship of increased use of pesticides,
including DDT, to the development of prostate cancer needs further examination.

III. Methods
Subjects
Recruitment

The subjects for this study were members of the Charleston Heart Study, a
prospective cohort study which was begun for the investigation of cardiovascular risk
factors among black and white adults. A cross-sectional survey of the Charleston County
population 35 years of age and older was devised during 1959 by Drs. E. Boyle, R. V.
Moore, and M .Z. Nichaman for obtaining prevalence data. The sample was based on
the 1950 census and was drawn by Dr. Alva Finkner of the Research Triangle Institute of
Durham, NC. The county was divided into the city proper, the urban fringe, the open
country and rural places. These areas were subdivided into units of twelve households
each. One hundred and sixty units were selected. All adults 35 years of age and older
were approached for recruitment into the study (Boyle et al., 1967).
The survey was physically conducted in the Charleston community between April
1960 and December 1961. A mobile trailer was utilized to examine the study subjects (at
their place of residence) by a staff consisting of a registered nurse, public health advisor
and supervising physician. Community acceptance of the study was encouraged by
newspaper, radio and television publicity, and by letters soliciting aid from ministers and
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school principals. Repeated attempts were made to obtain cooperation from reluctant
subjects (Boyle et aI., 1967).

Response
The area sampling plan yielded a total sample of2601, of whom 2184 responded.
Three persons of "other" ethnic groups were found in the sample and eliminated from
further consideration, decreasing the sample to 2181 persons. This represented an overall
84% response rate and showed insignificant variations by age, race and sex.

Baseline exam
The 2181 persons who participated in the baseline examination included 653
white men, 741 white women, 333 black men and 454 black women. Demographic data
were collected on each subject, such as educational attainment and geographic family
origin. An abbreviated medical history was obtained. An electrocardiogram and
venipuncture were also performed. The blood obtained was analyzed for serum
cholesterol, beta lipoprotein, type (A, B, 0, AB) and hemoglobin electrophoresis.
A structured interview at the baseline examination was used to determine
residence, occupation, education, and tobacco use. The following table contains the
questions asked of each participant for obtaining these specific data. Occupation was
recorded as indicated by the participant and later coded by the investigators into the
categories listed in the table. Education was later recoded to reflect the total number of
years of attainment.
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Table 2
Excerpts from the Baseline Questionnaire (1960)

Residence
Where did you live the first 20 years of your life?
Urban

Rural

Mixed

Where did you live from age 20-65 ?
Urban

Rural

Mixed

Occupation
What is/was your Occupation? _ _ _ _ _ _ _ __

O. Professional
1. Military service personnel
2. Farmers and farm managers (owners & tenants)
3. Proprietors, managers and officials (non-farm)
4. Clerical, sales, and kindred workers
5. Craftsmen, foremen, and kindred workers
6. Operative and kindred workers
7. Protective service workers and service workers
8. Farm laborers and foremen
9. Laborers except farm and household
10. Housewives
Education
What is the highest level of education you have completed?
Elementa-ry: 1 2 3 4 5 6 7 8
High School: 1 2 3 4
College:
123 4

Tobacco Use
Do you use tobacco? _

Yes _No

If no, ever used it? _ _ Yes _

No

Years using _ __
Years since use

--
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Follow-Up Exams and Interviews
The following sections describe the overall purpose and number of subjects who
participated in the subsequent follow-up examinations, referred to as phases. The
descriptions focus only on the information used to address the specific aims for this
project.

Phase III (1963)
In 1963 there was a selective re-examination of 1402 subjects from the original
cohort. This subsample consisted of273 persons with EKG abnormalities determined
from the baseline exam. Two controls of the same race, sex, and cholesterol level for
each subject with an abnormality were also included. Additionally 1152 participants
were selected from four cholesterol categories ( < 190, 190-229, 230-269, < 270) as
determined by their 1960 data. This sampling plan resulted in an overlap of 659 subjects
and in ten instances there was only one control available per subject with an EKG
abnormality. Another purpose of this recall was to increase the number of high
socioeconomic (SES) black men since the random selection process used in the initial
phase yielded an insignificant number in this strata. Inclusion in this socioeconomic
group was verified by the Maguire social scale which considered occupation, income,
education and professional attainment, residence location and appearance, and religion.
This recruitment effort resulted in an addition of 102 high SES black men into the CHS
cohort, thus increasing the total sample size to 2283 participants.
The examination procedure consisted of a brief medical history and interview.
Although the interview solicited some of the same information collected at baseline, such
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as occupation, education and tobacco use, it was expanded to include questions regarding
other potentially important exposures and characteristics. The following table contains a
reproduction of the selected questions from the 1963 interview used in the current study.
The source of water supply was categorized as either city, surface, artesian or other.
Physical activity questions were asked to gain information on both current and past level
of activity.

Table 3
Excerpts from the 1963 Questionnaire
Occupation
What is/was your Occupation ?_ _ _ _ _ _ _ _ _ __
Education
What is the highest level of education you have completed? __
Tobacco Use
Do you use tobacco? _

Years using _ _ __

Yes _No

If no, ever used it? __ Yes _

No

Years since use

---

Water Supply
Do you have "city water" in your house?
In no, surface

artesian

other

yes

---

Physical Activity
What is your physical activity level now?
_

sedentary _light __ medium __ heavy _

very heavy

What was your physical activity level 10 years ago?
_

sedentary _light __ medium _ _ heavy _

very heavy
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Phase VII (1974175)

In 1974/75, all survivors of the cohort were asked to participate in the coronary

disease incidence recall. There was a subsample of 1434 members of the cohort who
chose to comply; yielding an 84 % response rate. At this time a detailed questionnaire
was administered by trained surveyors and serum samples were collected. Information
was collected on a number of variables including age, education, body mass index (BMI),
smoking status and serum total cholesterol. Because of an ancillary interest in examining
the association between DDT, blood pressure and skin color, three questions regarding
pesticide use and DDT exposure were asked of each participant.
Table 4 contains the questions related to pesticide use.

Table 4
Pesticide Questions from 1974/75 Questionnaire
Have you ever worked with pesticides?

YES

NO

Do you use pesticides around the home?

YES

NO

Have you been exposed to DDT?

YES

NO

Number of years _ _ _ __

If yes, give details _ _ _ _ _ _ __

Serum samples were collected and p,p'DDE measurements were made by gas
chromatography using the Dale-Cueto modified method. Measurements were recorded in
parts per billion with a detection limit of 1ppb (Dale et al., 1966; Keil et al., 1972).
DDE measurements were not made on all who were interviewed because only 898
of the participants, including 319 white women, 84 black women, 300 white men, and

33
195 black men agreed to have their blood drawn. Thus, only 898 subjects who had DDE
measurements were available for many analyses. Answers to the questions regarding
pesticides were not answered by two white women, thus decreasing the sample size to
896 for analyses using these variables. Thirty-four participants failed to answer the
question, which specifically addressed exposure to DDT.

Phase X (1984/85)

The recall in 1984/85 was a 25-year follow-up designed to ascertain the vital
status of the cohort. While there was no physical exam, a rather detailed questionnaire
was used to gather updated information on demographics, physical functioning status and
medical histories. The survivors were contacted by phone to schedule an appointment,
and then an experienced interviewer made in-house visits to administer the questionnaire
and record height, weight and blood pressure. A total of 1246 participated in this recall.
Although a medical history was included, cancer history was omitted.

Phase XI (1987/89)

In 1987/89, there was a comprehensive physical examination and assessment of
functional status for each participant. The survivors of the cohort were contacted and
asked to come to the Medical University for the examination and interview. Of the 1079
subjects who were still living: 693 came into the clinic, 176 had home interviews, 126
had phone interviews, 57 refused and 27 did not participate for other reasons. Questions
regarding cancer history were included in this interview, and Table 5 lists these questions.
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Table 5
Cancer History Questions in 1987/89

Has a doctor ever told you that you had any of the following diseases?
If yes, please indicate date of onset.
Date
Skin Cancer

Yes

No

DK

- -/- -

Breast Cancer

Yes

No

DK

- -/- -

Bladder Cancer

Yes

No

DK

- -1- -

Lung Cancer

Yes

No

DK

- -/- -

Other Cancer

Yes

No

DK

- -/- -

Phase XII (1990/91)
In 1990/91, survivors of the cohort were again examined for coronary heart
disease (CHD) and functional status. Of the 965 members still living, 496 came into the
clinic, 241 required home interviews, 180 had telephone interviews, and 48 refused.
Questions regarding cancer history that were included in this interview are listed in Table
6.
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Table 6
Cancer History Questions in 1990/91

Has a doctor ever told you that you had any of the following diseases?
If yes, please indicate date of onset.

Date
Skin Cancer

Yes

No

DK

- -/- -

Breast Cancer

Yes

No

DK

- -/- -

Bladder Cancer

Yes

No

DK

- -1- -

Lung Cancer

Yes

No

DK

- -1- -

Esophageal Cancer

Yes

No

DK

- -1- -

Prostate Cancer

Yes

No

DK

- -1- -

Other Cancer

Yes

No

DK

- -1- -

Specify

Phase XIII (1994/95)

In 1994/95, a follow-up interview was conducted to obtain the vital status and the

cancer history of the 898 participants who had DDT measurements made in 1974/75, as
well as from all survivors of the cohort. This follow-up included 345 survivors without
DDT measurements. All participants were contacted by phone, and if the participant was
deceased, a proxy was located. There were 659 interviews completed by the participants
themselves and 584 interviews completed by proxy. For more than half of the deceased
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subjects, their surviving spouse provided the requested information. In other instances,
when the spouse was not available, a child or sibling of the deceased served as a proxy.
The questionnaire was designed to update the subject's medical history, including all

cancers. Information was obtained so that cancers could be classified by site. Listed
below (Table 7) are the questions regarding cancer history addressed to both men and

women. A separate questionnaire, addressed to women only, was designed to obtain
information on risk factors for breast cancer. These questions are listed in Table 8.

Table 7
Cancer History Questions in 1994/95

Men and Women

Has a doctor ever told you that you had cancer?
If yes, please indicate date of onset.
Cancer

No

Yes

Date:

/

If yes, please provide the following additional information.
Where was it located?

---------------------

Were you hospitalized?_ _ _ _ _ _ _ _ _ __
Which hospital?_ _ _ _ _ _ _ _ _ _ _ __
Who was your doctor?_ _ _ _ _ _ _ _ _ __
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Table 8
Breast Cancer Risk Factors 1994/95

Women Only

How many times have you been pregnant? _ _
How many children have you had? _ _ Sons _ _ Daughters
How old were you when you had your first child? _ _
Did you breast feed your children? No Yes Don't Know
If yes, how many of your children? _ _

Have any of the following women in your family ever had breast cancer?
Mother............... No Yes Don't Know
Don't Know
Sister.................. No Yes Had no sisters
Daughter............ No Yes Had no daughters Don't Know
Has a doctor ever told you that you had benign breast disease? No Yes
Have you had a hysterectomy? No Yes Don't Know
If so, how old were you? _ _
Were the ovaries removed? No Yes Don't Know
Have you ever had a mammogram? No Yes Don't Know
If yes, When was your last mammogram? _ _ _ _ __
Have you ever taken a hormone replacement? No
If yes, how many years did you use it?

Yes Don't Know

Summary ofFollow-Up Exams
The outcomes of interest for this project were both cancer incidence and cancer
mortality. As described in the previous sections, information to determine cancer
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incidence was obtained in several follow-up periods (phases). These times were 1987/88,
1990/91 and 1994/95. Mortality is addressed in the following section.

Mortality
The vital status of the cohort was monitored through the various recalls of the
original cohort. The underlying cause of death from nosologists' coding of death
certificates was used to classify the deaths. International Classification of Diseases, ninth
revision (ICD9) codes 140.0 through 239.9 (excluding benign neoplasms) were used to
define cancer mortality. For the period of 1960-1994, there were 294 cancer deaths and
86% of these were verified by hospital and pathology reports. The remaining 14 % were
unable to be verified because the medical records were not available. Over the 34-year
period (1960-1994) there were 52 individuals lost to follow-up. The closing date for this
study was December 31, 1994.

Statistical Analysis
Specific Aim J
To describe the cancer mortality patterns with reference to environmental factors
collected at the 1960 baseline or 1963 re-examination, including
a. residence
b. occupation
c. education
d. tobacco use
e. water supply
f. physical activity
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Descriptive Statistics
A number of putative risk variables measured in 1960/63 were examined in a

univariate fashion to determine if they were associated with cancer mortality. For these
analyses all variables except age were considered categorically: race as white, black or
high SES black; educational attainment as less than high school, less than college
graduation, less than advanced degree, or advanced degree; water supply as city, surface,
artesian, or other; residence as urban, rural, or suburban; occupation as farmers, manager
and sales, laborer, military, professional, or housewife; physical activity as sedentary,
light, medium, heavy, or very heavy; current smoking as status as yes or no; and gender
as male or female. All comparisons for the categorical variables were made using a chisquare test. If the contingency table had a cell count less than 5, then the p ..value from
Fisher's Exact test was used. A Student's t-test was used to compare the mean difference
in age for those dying of cancer to those not dying of cancer.
Logistic regression models were constructed to test the association of each
variable with cancer mortality adjusting for age, gender and race. For these analyses,
education and physical activity were categorized into smaller categories with education
collapsed into two groups: high school education versus less than high school education
and physical activity was categorized as high and medium versus light activity. Logistic
regression was perfonned to determine the magnitude of the effect that a particular
variable had on the outcome (cancer mortality) while adjusting, or ignoring, the effect of
the other variables. Logistic regression is a mathematical modeling approach used to
describe the relationship of several independent variables to a categorical dependent
variable (Kleinbaum, 1991). In this situation, the dependent variable in the model was
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cancer mortality status and a series of independent variables were evaluated adjusting for
the effects of age, race and gender. For example, the model to determine if tobacco use
was associated with cancer adjusting for the effects of age, race and gender would be
expressed by the following model:
Ycancer =

Po +

~smokingXsmoking + Page X age +

Prace X race +

P sex X sex .

The Pcoefficients were unknown parameters that were estimated based on the data
observed for the subjects. Maximum likelihood estimation procedures were used to
obtain the estimates of the PI's. Each PI represented the change in the log odds that
results from a one unit change in the independent variable when all other X's were fixed.
For dichotomous variables, such as smoking, the values were 0 (no) or 1 (yes). Therefore
the Psmoking represented the change in the log odds that would result from subjects who
smoke relative to those who did not smoke while holding the other independent variables
constant. Thus, the adjusted odds ratio for each dichotomous (0,1) variable in the logistic
model was obtained by exponentiating the coefficient corresponding to that variable, e.g.
eP=OR.

Survival Analysis
A second approach that incorporated the length of follow-up was used to evaluate
the association of environmental factors with cancer mortality. Survival analysis, using
Cox proportional hazard regression, was used to estimate the relative risk of cancer
mortality. This particular analysis strategy was important because it considered the time
element inherent in a prospective design. For the models specified, time until death or
end of study was used to define the time each person was considered at risk. Models
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were constructed for cancer mortality as the outcome measure, and the independent
measures included a number of categorical variables: smoking, water supply, occupation,
residence, physical activity and education. Additional models adjusted for age, race and
gender. The approach to obtain the relative risk (RR) estimates was not to get the best fit
of the model, although this was also examined, but rather the focus was on quantifying
the risk of the putative factors for this cohort.
Cox proportional hazards modeling has become a popular mathematical tool used
for analyzing survival data. Briefly described, the Cox model provides an expression for
the hazard at time 1 for explanatory variables, or predictor variables. This model contains
two components, a baseline hazard function of time and an exponential function
involving the explanatory variables but not time. For example, the model to determine if
tobacco use is associated with cancer adjusting for the effects of age, race and gender is
represented as:
h(I,X) =

110 (I) eJ30 + J3 smoking X smoking +

The parameters are the

~'s

f3age X age + J3 race X race + J3 sex X sex.

and they are estimated with maximum likelihood (ML)

procedures. Once the ML estimates are obtained, the interest lies in the statistical
inferences about hazard ratios defined in terms of these estimates. A hazard ratio is
defined as the hazard for one individual h(l, X*) divided by the hazard for a different
individual h(l, X), where X* denotes the set of predicators for one individual and X
denotes the set of predictors for the other individual. Thus, the hazard ratio is computed
by exponentiating the sum of each of the estimated f3i'S times the difference between Xi·
and Xi- The hazard ratio for the effect of a (0,1) variable which adjusts for other variables
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is obtained by exponentiating the estimated coefficient of the variable (Kleinbaum, 1995).
For example, the hazard ratio for tobacco use (smoking) is represented as:
HR = exp

[J3 smoking X smoking + J3 age X

age

+

P race X race + Psex X sex] .

The hazard function, h(t), gives the instantaneous potential per unit time for the event to
occur, given that the individual has survived up to time t. Note that the hazard function
focuses on the failure of an event, for example cancer death. The model assumes
proportionality of the hazard rates, or equivalently, that the hazard for one individual is
proportional to the hazard for any other individual, independent of time. This assumption
was verified for our data by creating a time-dependent variable in which the Cox model
was extended to contain a product term involving the time-independent variable being
assessed (such as DDE) and some function of time. The null hypothesis for the
proportionality assumption was that this product term would be zero (Kleinbaum, 1995).
If the associated p-value was greater than 0.05 then the proportionality assumption was
verified and the Cox model reduced to its original form (Kleinbaum, 1995).

Specific Aim 2
To quantify the association between pesticide exposure and cancer mortality
uSing:
a. self-reported use of pesticides
b. serum DDE levels
and to compare the utility of self-reported data.

Self-Reported Use
As described in a previous section, pesticide use was reported by subjects during
the Phase VII interview. If anyone of the three questions asked in the interview
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regarding pesticide use was answered "yes" then the individual was considered as being
exposed to pesticides. If all three questions were answered "no" then the subject was
categorized as not using pesticides. Contingency tables were constructed to test the
association of reported use with cancer mortality. Crude relative risks were calculated
from these tables. The risk estimates were for all subjects and also for each race, sex and
race-sex group. Similar analyses were used to explore the association of cancer mortality
with the self-reported use of DDT.

SerumDDE
The distribution of serum DDE was examined among the 898 participants and
divided into tertiles, quartiles and quintiles. There was only one subject with a trace level
of DDE; a value of 0.5 ppb was assigned for the purpose of statistical analyses for that
subject. Cutpoints ofDDE tertiles, quartiles and quintiles were determined using
frequency tables for the combined study sample, for the gender specific groups and racegender specific groups.

Descriptive Statistics
The putative risk variables measured in 1974/75 were examined univariately to
determine if they were risk factors for cancer mortality and/or associated with DDE, using
both the reported use data and actual serum measurements. The putative risk factors
included age (measured in years), education (measured in years), BMI (measured in
kg/m2 ), cholesterol (measured in mgldl), race (categorized as white, black or high SES
black), gender (male or female) and smoking status (current or not).
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There were 27 subjects who had missing BMI values and 9 who had missing
cholesterol levels. Averages from previous examinations were substituted for these
missing data. DDE levels and all covariates pertained to 1974/75 and were not reevaluated during the follow-up period. Measurements were available on 898 subjects out
of the 1434 who participated in Phase VII; those with DDT measurements were slightly
younger (59.9 vs. 62.1 years), more likely to be male (75 vs. 50 %), more likely to be
white (70 vs. 50 %) and had slightly higher levels of education (9.8 vs. 8.3 years) as
compared to participants for whom no blood specimens were obtained. There was no
difference in average cholesterol values and the percentage who reported current smoking
between those who provided blood samples and those who did not.
The putative risk factors were compared across tertiles ofDDE for both the entire
cohort and separately for men and women (using gender specific cutpoints) to determine
the level of association. Additional models were constructed for adjustment of age,
gender and race. The ordinal trend test across DDE values was performed for categorical
variables using logistic regression and for the continuous variables with a linear
regression test. These models for trend included DDE as an ordinal variable representing
the tertile level as the independent measure while the putative risk variable was the
dependent measure.
Frequency tables were also constructed for each of these variables to determine
their association with cancer status. All comparisons for the categorical variables were
made using a chi-square test. If a 2x2 table had a cell count less than 5, then the p-value
from Fisher's Exact test was used. Student's t-tests were used to compare the mean
differences in the continuous variables for the two groups of subjects: those who died of
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cancer versus the remaining cohort. Additionally, tests to determine the association of
each risk factor with cancer mortality were constructed adjusting for age, gender and race
using logistic regression.

Standardized Mortality Ratio
Standardized Mortality Ratios (SMR) were computed using the United States
population as the external comparison group. The expected death rates were provided by
the Center for Disease Control and Prevention (1979-1994; on-line
http://wonder.cdc.gov) and National Cancer Institute (1974-1978; 1987 Annual Cancer
Statistic Review) databases (CDC, 1997; NCI, 1987). The cancer mortality was defined
by ICD9 codes 140-239 (excluding the benign neoplasms). The expected rates were
stratified by age groups (35-44, 45-54, 55-64, 65-74, 75-84, >85) and by year (1974-79,
1980-84, 1985-89, 1990-94). Rates were constructed for age, calendar year and DDE
tertiles; and all combinations of these.
The observed number of deaths and person-years in this cohort was computed for
each age, calendar year and/or DDE tertile. The person-years of observation for each
subject was calculated as the length of time between entry into the study and time of
death or censoring date (December 31, 1994). Crude rates were calculated by dividing
the observed number of deaths by the number of person-years within each strata and
recorded per 100,000 person-years. The expected number of deaths was computed by
multiplying the expected death rate (obtained from the mentioned databases) by the
person-years observed in each category (age, year, DDE tertile). The SMR was obtained
by dividing the total number of observed deaths by the sum of the expected deaths.

46

Because there was no standardized database for nnE measurements, the expected death
rate was assumed to remain constant across the tertiles of nnE. The marginal totals for
the tertiles estimated the SMR adjusted for age group and calendar year. These values
were then used to produce a summary table. (Appendix C contains the entire set of data
generated for the SMR.) Relative risks and their 95% confidence intervals were
estimated using maximum likelihood estimation procedures. Tests for homogeneity and
trend were calculated also using these estimation procedures (Breslow & Day, 1987).

Poisson Regression
The rates calculated for the SMR were assumed to have a Poisson distribution.
Poisson regression models were constructed using the SAS® Procedure GENMOD. The
coefficients and standard error resulting from the model were used to generate estimates
of relative risk for cancer mortality. The outcome measure in Poisson regression was a
rate derived from the total number of cancer deaths observed in the cohort, as the
numerator, and the expected number of deaths as the denominator. The regression model
was repeated using an internal comparison by substituting the observed person years for
the denominator (Breslow & Day, 1987). The antilogarithm of the coefficient was used
to estimate the RR.

Survival Analysis
Survival analysis using Cox proportional hazard regression was used to estimate
the relative risk using SAS® PHREG. As discussed previously, this method allowed for
adjustment of covariates and incorporated the length of follow-up. DDE was included in
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the models as a categorical variable in the form of tertiles, quartiles, and quintiles.
Models were constructed including both self-reported use of pesticides and history of
DDT use. The length of follow-up was determined as the interval between either the date
of death or the end of study for each subject and the date of the phase VII visit. Cancer
mortality was the outcome measure. Models using the combined, gender specific and
race-gender cutpoints were constructed. Proportionality of the hazard rates were verified
in the manner previously discussed.
In this study, the purpose of model selection was not to determine the best fit of

the model but rather to explain the relationship of DDE and cancer mortality adjusting for
known risk factors. One model adjusted for age only and another model labeled as the
fully adjusted model included the other six covariates. Site specific analyses with models
for lung, digestive, lymphatic and leukemia, and hormone-related cancers were also
performed to determine if these particular cancers were associated with DOE.
Survival analyses were also completed where ODE was included in the model as a
continuous variable. The association beyond linearity was checked with polynomial
regression, including a variable for linear, quadratic and cubic relationships. To avoid
multicolinearity problems, the data were centered by subtracting the group mean from the
individual ODE value. Tnree models were constructed: the first model included a term for
linear association (DOE); the second model included the linear variable and added a
quadratic term (DOE + ODE2) ; the third model included the linear term, quadratic term
and cubic term (DOE + DDE2 + DDE3) shown below.

Y=Po+ f31X+ P2X2+

P3 X3
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This model represented a third order model with one independent variable, DDE. Note
again, the independent variables were expressed as deviations around the mean, since X,
X 2 , and X 3 are often highly correlated (Neter et al., 1989).
Survival analyses were done using combined cutpoints, gender specific cutpoints
and race specific cutpoints. The coefficients for the model and the p-value for
significance were recorded. This analysis was repeated with adjustment for covariates.

Reported Use versus Measured Levels
The self-reported use of pesticides was compared to the actual levels ofp,p'DDE
measured at the time of the interview. Mean levels ofDDE and the standard deviations
were calculated for the cohort and compared for self-reported use. These measures were
stratified by race and gender. Student's t-tests compared the mean differences for those
who reported use compared to those who did not.

Specific Aim 3
To test the hypothesis that an increased risk of breast and prostate cancer are
associated with increasing levels ofDDE.

Nested Case-Control Design
Whereas the previous specific aims investigated the risk ofDDE levels associated
with cancer mortality, this specific aim addressed cancer incidence. The particular
outcomes evaluated were breast cancer in women and prostate cancer in men. A nested
case-control approach was used in which the subjects were selected from those 898
participants who had DDT measurements made in 1974/75, and who were followed
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prospectively over the next twenty years. Eight women had diagnosed breast cancer and
two men had diagnosed prostate cancer before the time of DDT measurement in 1974/75
and were not included in the statistical analyses. Thus, 395 women and 493 men who
supplied a serum sample, and who also had a negative history of cancer at the 1974/75
examination, made up the pool of subjects available for the nested case control study.
Cohort members who developed breast or prostate cancer were included as cases
in the matched design. Four control subjects were matched to each case. Control
subjects were selected at random from risk sets consisting of all cohort members who
were free of cancer and who matched the case patient on race and age (± 3 years). In one
case, there was an insufficient number of cases within the three year age range from
which to draw and the range was extended.

SerumDDE
Comparisons ofDDE levels in case patients and their controls were made by
matched analysis using t-tests. The distribution of serum DDE was examined and divided
into tertiles. Estimated relative risk, the odds ratio (OR), was determined by conditional
multiple logistic regression with DDE included in the model as the exposure variable.
Regression models were evaluated with DDE expressed in tertiles and also in a
continuous form. The relationship between serum ODE with breast cancer and prostate
cancer was adjusted for covariates collected in 1974 or prior. Particular covariates were
chosen because they had been identified as risk factors in other studies. Multivariate
analyses were performed with SAS® PHREG procedure.
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Descriptive Statistics

The putative risk variables measured in 1974/75 were examined univariately to
determine if they were a risk factor for cancer mortality and/or associated with DOE. The
variables included age (measured in years), education (measured in years), BMI
(measured in kglm2), cholesterol (measured in mg/dl), race (white, black or high SES
black), gender (male or female) and smoking (current or not). As described in a previous
section, the potential risk variables for breast cancer were collected in the 1994/95
follow-up. These included nulliparous status (never pregnant or have had at least one
pregnancy), lactation history (have breast fed, never breast fed, or unknown), positive
family history of breast cancer (mother, sister or daughter had breast cancer, or mother,
sister, and daughter did not, or unknown status), and age at first full term pregnancy ( 30
years or greater, < 30 years, or unknown status).
The putative risk factors were compared across tertiles ofDDE. The test for linear
trend across DDE values was computed for categorical variables using logistic regression
and for the continuous variables using linear regression. These models included DDE
coded as an ordinal variable to represent the tertile level as the independent measure and
each risk factor as the dependent measure.
Frequency tables were also constructed for each of these variables to test their
association with cancer incidence. All comparisons for the categorical variables were
made using a chi-square test. If a 2x2 table had a cell count less than 5, then the p-value
from Fisher's Exact test was used. For comparisons involving continuous variables,
Student's t-tests were used to compare the mean differences for those with cancer to those
without. Matched analysis was performed by comparing the case patient to hislher four
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age and race matched controls. The tests which involved continuous variables were
constructed by creating a variable to obtain the difference of the selected risk factor for
the case subject and each of the four matched controls. A simple one sample t-test was
performed to determine if this score differed from zero. For categorical risk factors, a
chi-square statistic with one degree of freedom was calculated to test the association
between the case and matched controls. This statistic was computed by creating a
frequency table obtaining the marginal totals of the selected variable. The formula used
for this analysis is shown below.

Case
J=1

Xl2

=

1=1

Xll

1=2

X2I

1= n

XnI

Controls
J=2

J=m

Xn2

[fm - 1) X++ - m(X++ - X+l) ]2
m X++ - IXi+2

where n
m

= number of cases;
=

1 + number of controls;

I = 1, 2, ... n
J

=

1, 2, ... m
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Conditional Logistic Regression
Conditional logistic regression models were constructed to examine the estimated
risk for breast cancer in women and prostate cancer in men. Conditional maximum
likelihood estimation was used because of the matched case-control design.
Unconditional estimation would require the model to be invariably large due to the
number of dummy variables required to reflect the matching strata. Furthermore, the
conditional approach gives unbiased estimates in this setting. Modeling matched data
requires the matched set to be considered in strata (Kleinbaum, 1991). The strata were
determined by the age and race matched sets. Among breast cancers, there were 105
persons in 21 matched sets, or strata. Each strata contained 5 persons, one of whom was
a case and the other 4 were the matched controls. In the prostate cancer design, there were
112 persons in 28 matched sets.
Multivariable matched conditional logistic regression analyses, which permitted
adjusting of covariates not used as matching criteria, were conducted with the PHREG
procedure in SAS®. The likelihood maximized by PROC PHREG was made identical to
the likelihood for the conditional logistic regression through modification of the data set.
For the 1:4 matched data, the likelihood for conditional logistic regression reduced to that
of the Cox model for the continuous time scale. This conditional logistic regression was a
stratified analysis, where each matched set was a stratum. A time variable was created so
that all cases in a matched set or stratum had the same event time value and so the
corresponding controls were censored at later times. The steps taken to perform this
analysis are briefly described here (SAS, 1995).
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•

First, age and race strata were formed for

eac~

matched set. For breast cancer there

were 21 matched sets and for prostate cancer there were 28 matched sets.
•

Two variables were specified on the left side of the equality in the Cox model
statement: a variable that contained a time of occurrence of an event (STATUS) and
a variable that indicated whether or not the observation was censored (FNDX).

•

STATUS was simply a dummy variable, constructed so that the time of the event for
cases was less than that for all controls in the same stratum. STATUS was defined to
be equal to 1 for the cases and as 2 for the controls.

•

FNDX was the variable used to indicate whether a subject was a case (FNOX=l) or
control (FNDX=O). The statement, FNDX(O), cause PROC PHREG to treat the
controls as censored.
Example of a model to determine if cancer was associated with DDE adjusting for
education, matched on age and race as previously described, is shown below.
Model STATUS*FNDX(O) = DDE education.

Power
The nested case control study of breast and prostate cancer used matching to
control for race and age. This study design was chosen so that comparisons of our work
with previously published studies: for example, Wolff et a1. and Krieger et a1. could be
made more easily. However this study design made it difficult to calculate the statistical
power, and three approaches were considered. To calculate power in a matched design
with multiple controls per case, and where the exposure level was not dichotomous would
require solving a system of non-linear equations (Breslow & Day, 1980). Thus, this
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approach was not feasible. The second approach where Breslow and Day reported
solutions for sample size and power under the conditions of 1:M matching with a
dichotomous exposure was considered. This technique where the exposure was
categorized into tertiles, would require a comparison of tertile 1 vs 2 and tertile 1 vs 3. In
the process of creating dichotomous groupings, some of the subjects were necessarily
eliminated. For example, comparing those in the highest tertile to those in the lowest
would eliminate the subjects in the middle tertile.. Furthermore, because cases and
controls would often be in different tertiles, it created a mUltiple control atmosphere and
complicated the situation. However, if the latter problem was ignored, a 1:4 matching for
a dichotomous exposure yielded a power of 80 % to detect an OR of at least 4.5 for either
breast or prostate cancer when 30 % of the population was considered to be exposed.
A third approach was considered in which the statistical power of the study was
estimated using an unequal case-control ratio in an unmatched setting (Schlesselman,
1982). The formula used for this analysis is presented as:
Zp = [n (PI - PO)2 I ( 1 + lie) p' q'

]112 -

Za.

where,

Po =exposured rate among controls in the target population
c = number of controls per case = 4
n = number of cases
PI= (Po R) I (1 + (Po - R))
p' = (P 1+ cpo) I (1 + c)
q' = 1 - p'

The power was calculated as:
Power = P(Z < Zp )
The following sections present the power of the analyses for a range of risk estimates,
assuming that 30 % of the population was exposed to high levels of DDT and
a = 0.05
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Breast Cancer
In the Charleston cohort, there were 21 breast cancer cases identified over the twentyyear period and these were matched to 4 controls by race and age which totaled 84
controls.

Table 9
Statistical Power of the Study Design with 21 Cases and 84 Non-cases
Odds Ratio

2.0

Power(%)
40

3.5

72
82

4.0

88

4.5

92

5.0

94

3.0

Prostate Cancer
In the Charleston cohort, there were 28 prostate cancer cases identified over the twentyyear period and these were matched to 4 controls by race and age which totaled 112
controls.

Table 10
Statistical Power of the Study Design with 28 Cases and 112 Non-cases
Odds Ratio
2.0

3.0
3.54.0

4.5
5.0

Power
50
82

90
95
97
98
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Meta-Analysis
A meta-analysis of the case-control studies of breast cancer and DDE/published to
!

date thus far was performed. The ratio of mean concentrations was used as theeffec\
measure. For each study the delta method was used to determine the variance of the log
of the ratio of mean concentrations. This formula was derived as:

For case-control studies, the summary ratios of the mean concentrations ofDDE
between cases and controls were derived from the weighted averages of the logarithm of
the ratios from the individual studies. Weights were taken to be proportional to the
inverse variance of the log ratios of the mean concentrations. The variance of the
summary measure was taken to be the inverse of the sum of the weights (Adami et al.,
1995).

IV. Results
Specific Aim 1
To describe the cancer mortality patterns with reference to environmental factors
collected at the 1960 baseline or 1963 re-examination, including
a. residence
b. occupation
c. education
d. tobacco use
e. water supply
f. physical activity

Vital Statistics and Cancer Mortality
Table 11 gives the vital status of the Charleston Heart Study (CHS) from baseline
through December 31, 1994. During the thirty-four year follow-up over half of the cohort
died, yielding a total of 1463 deaths. More deaths occurred among men than women with a
greater proportionate mortality in black men and women. Four hundred sixty-three (71 %) of
the white men died, 251 (75 %) of black men died and 46 (45 %) of the high SES black men
died. Among the white women there were 403 deaths and among the black women there
were 300 deaths which accounted for 54 %, and 66 % in the race-gender groups respectively.
There were 294 cancer deaths observed over the thirty-four year follow-up period:
1960-1994. Overall, these accounted for 20 percent of all deaths. Among white men, 104 of
the 463 (16 %) deaths were due to cancer. Similarly, the proportion of deaths due to cancer
were 18% (46/251) for black men, 26 % (12/46) for high SES black men, 21 % (86/403) for
white women and 15 % (46/300) for black women.
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Table 11
Vital Statistics for Charleston Heart Study
1960-1994

N

All
Deaths

White Men
Black Men
High SES Black Men*

653
333
102
1088

463
251
46
760

104
46
12
162

175
77
55
307

15
5
_1
21

White Women
Black Women

741
454
1195

403
300
703

86
46
132

318
143
461

20

11

2283

1463

294

768

52

Total

Cancer
Deaths

Alive

Unknown

31

*Recruited in the 1963 recall

The distribution of cancer deaths by anatomical site is listed in Table 12. Because of
the small number of deaths for some cancer sites, groupings were created from the
International Classification of Diseases (leD) codes. Lung cancer occurred with the highest
frequency overall as well as for the men. It was the second most frequent type of cancer
among the women. Digestive tract cancers which included esophagus, colon, small intestine,
rectum, liver, stomach, gall bladder, and pancreas accounted for more of the cancer deaths for
the women than any of the other types. There were 37 digestive cancer deaths for both men
and women, making this the most frequent type in the women and the second most frequent
type in the men. There were 21 prostate cancer deaths and 21 breast cancer deaths, with only
one breast cancer occurring in the men.
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Table 12
Frequency of Cancer Deaths (1960-1994) by Site
Cancer Site (ICD Code*)
Total Deaths
74
Digestive System (150-159)
Respiratory System (160-165)
88
Breast (174)
21
11
Female Genitourinary (179-184)
21
Prostate (185)
Bladder (188)
5
7
Kidney (189)
Brain & Nervous System (191,192) 8
11
Lymphatic System (200-203)
Leukemia (204-207)
8
Other (141,148,149,171,172)
7
Unspecified sites & behavior
33
(195-199; 236-239)
294
Total

Men
37
61
1

o

Women
37
27
20
11

o

21
4
4
4
4
6

1
3
4
7
2

5

2

15

18

164

132

* International Classification of Diseases, Revision 8 and 9

Environmental Risk Factors
Descriptive statistics for the environmental risk factors measured in 1960/63 were
obtained. Table 13 shows univariate comparisons of these potential risk factors for those
who subsequently died of cancer causes versus those not dying or dying of other causes. The
statistical significance (p-value) presented in the table was determined from two methods:
the unadjusted value from pooled t-tests or chi-square analysis and the adjusted value from
logistic regression models which included age, gender and race. There was a borderline
statistically significant difference for age. The average age at baseline was 50.8 for those
who died of cancer during the follow-up while the average age was 49.7 for those not dying
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of cancer. More men died from cancer than women. There was little difference in the
proportion of cancer deaths between the two race groups. Because cancer mortality has been
shown to be associated with age, race and gender in other studies, the environmental risk
factors (occupation, physical activity, smoking, residence and water supply) were all adjusted
for age, race and gender. For each occupation, the association with cancer mortality was
evaluated relative to all other occupations. There was a statistically significant association of
cancer mortality status with two of the occupational groups, laborer and housewives. Having
an occupation of a non-farm lahorer compared to all other occupations was significantly
associated with cancer mortality. Almost 48 % of those who died of cancer had been nonfarm laborers compared to 40.9 % of those who did not die of cancer. Also among those who
did not die of cancer, there were 28.8 % who reported their occupation as housewife, whereas
among those who died of cancer there were 21.3 % who were housewives. No other
occupational group was significantly associated with cancer mortality status. There was also
no statistically significant association observed between educational status and cancer
mortality. For the physical activity category, both the current level and the level 10 years
earlier more subjects reported a light activity level followed by medium and then heavy
activity levels. There was no statistical association for the level of reported physical fitness
and cancer mortality status. Current. cigarette smoking was found to be a risk factor for
cancer mortality in this cohort. The association persisted after adjustment for age, race and
gender (p < 0.01). Among those who died of cancer, 66.7 % were current smokers while of
those not dying of cancer 53.8 % were smokers. Before adjustment of the covariates, there
was also suggestion of an association between cancer mortality and residence; however, this
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Table 13
Environmental Risk Factors and Cancer Mortality

Variable
Age (mean, years)

Cancer Deaths
Unadjusted
n-value8
Yes
No
50.8
49.7 0.064

Adjusted
I!-valueb

Race (%, white)

64.6

60.5

0.195

Sex (%, male)

55.1

46.6

0.006

3.2
19.5
47.8
1.8
6.4
21.3

4.1
17.7
40.9
2.2
6.3
28.8

0.462
0.462
0.028
0.635
0.942
0.008

0.458
0.849
0.059
0.355
0.909
0.097

0.174

0.349

0.583

0.900

0.627

0.336

OccupationC (%)
Farmer (% yes vs all others)
Managers & Sales
Laborers
Military
Professional
Housewife
Education (%)
Less than high school
Up to high school
Up to college
Advanced

47.4
31.1
16.7
4.8

44.5
35.7
13.5
6.3

Reported Physical Activityd (%)
Ten years prior to 1963 recall:
Light
Medium
Heavy
In 1963 at recall:
Light
Medium
Heavy

53.8
32.2
14.1

52.0
36.1
12.0

68.5
24.2
7.4

70.5
24.1
5.4

66.7

53.8

0.001

0.001

Residencec
Resided from age 20-65 (%, Urban) 85.1
Resided first 20 years (%, Urban)
53.9

89.3
55.5

0.077
0.644

0.135
0.941

Water Supply (%, City)d

72.7

0.333

0.258

Smoking (%, Yes)

76.5

ap-value derived from pooled t-test or chi-square analyses
bAdjusted for age at baseline, race and sex
cHigh Socioeconomic Men Missing
d 1963 Recall only
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difference diminished upon adjustment for age, race and gender. There was also no
statistically significant association observed among water supply and subsequent cancer
mortality.
Analyses to detennine whether the presence of these environmental factors increased
the risk for cancer mortality were perfonned using Cox proportional hazards regression
models. Table 14 gives the RR estimated from the model with each variable adjusted for age,
race and sex. For all subjects collectively, there was no increased risk of cancer mortality
associated with any of the occupational groups. There was also no increased risk of cancer
mortality observed for those with a high school or higher education compared to those
without completing high school. Reporting a medium or higher level of current physical
activity at the time of the exam or ten years prior also showed no association with cancer
mortality.

Smoking was the only variable associated with an increased the risk for cancer in

this cohort. The risk of cancer for current smokers compared to non-smokers was almost
doubled. There was a suggestion of an increased risk for cancer mortality for rural residency
during the ages of 20-65; however, the upper confidence interval included 1.00. Those with
city water had an increased risk for cancer mortality; however, this risk was not statistically
significant. Multivariable models, not shown in Table 14, were constructed to detennine if
adjustment for all the factors would modify the relative risks. Smoking was found to be the
only statistically significant factor in the multivariable models.
The Cox proportional hazards regression was repeated for men and women separately.
The results for the gender specific analysis are also given in Table 14. The only difference in
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the gender specific models that was not observed in the entire cohort collectively occurred for
the occupational

Table 14
Relative Risks of Cancer Mortality from Selected Environmental Risk Factors
RR ( 95 % Confidence Intervals)
__
V~a.;;..;;;ri~ab;;;.;:l:.;;.;es:;...;f;;.;;.r...;;,;om=..;:I__9.-60__/.-63____.i ioi A__
lla (n = 2283)
Men b (0 = 1088)
Womeo b (0 = 1195)
Occupation
Farming
Housewife
Professional
Manager&Sales
Laborer
Military

0.75 (0.38, 1.49)
0.79(0.56,1.12)
0.84 (0.52, 1.36)
0.96 (0.69, 1.34)
1.30 (0.98, 1.75)
1.04 (0.42, 2.56)

0.82 (0.33, 2.03)
0.73 (0.37, 1.45)
0.78 (0.52, 1.18)
1.48 (1.03, 2.12)
0.68 (0.28, 1.68)

0.70 (0.25, 1.96)
0.79 (0.55,1.13)
1.00 (0.51, 1.98)
1.23 (0.78, 1.96)
1.35 (0.84, 2.02)

1.05 (0.77,1.44)
Education
High School and above

1.02 (0.68, 1.54)

1.09 (0.67, 1.78)

0.93 (0.70, 1.30)

1.14 (0.85, 1.53)

0.74 (0.47, 1.16)

0.96 (0.69, 1.42)

1.13 (0.82, 1.55)

0.76 (0.45, 1.31)

Smoking
Current smoker

1.73 (1.36, 2.20)

1.86 (1.32, 2.63)

1.65 (1.16,2.34)

Residence(20-65 years)
Urban

0.72 (0.54, 1.00)

0.78 (0.54, 1.13)

0.74 (0.50, 1.09)

Residence «20 years)
Urban

1.06 (0.88, 1.27)

1.11 (0.87, 1.41)

1.00 (0.76, 1.30)

Water Supply
City

1.39 (0.93, 2.06)

1.42 (0.83, 2.45)

1.32 (0.75, 2.43)

Physical Activity (10 yrs)
Medium and Heavy
Physical Activity (current)
Medium and Heavy

aRR derived from Cox regression models adjusted for age, race and gender
bRR derived from Cox regression models adjusted for age and race
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category of the non-fann laborers. The RR for men was 1.48 (el: 1.03,2.12) suggesting an
increased risk for cancer mortality for those men employed as non-farm laborers. Smoking
was found to be a risk factor for cancer mortality for both men and women. All other
environmental factors did not indicate an increased risk of cancer mortality for the men or
women.

Specific Aim 2
To quantify the association between pesticide exposure and cancer mortality using:
a. self-reported use of pesticides
b. serum DDE levels
and to compare the utility of self-reported use of pesticides.

Vital Statistics and Cancer Mortality
Among the 898 subjects who had serum levels ofDDE quantified in 1974/75, a total
of 438 (49 %) deaths occurred over the twenty-year follow-up period. The average length of
time in the study before cancer death was 16 years and ranged from 1 to 20 years. Overall,
there were 108 deaths (25%) attributed to cancer, as noted in Table 15. Among white men,
there were 179 (60 %) deaths of which 42 (24 %) were due to cancer; black men contributed
81 (63 %) deaths with 21 (23 %) of these deaths due to cancer, and for the high SES black
men there were 26 (39 %) total deaths with 6 (23 %) cancer deaths. Among white women,
there were 114 (36 %) deaths and 29 (25 %) of these deaths due to cancer. Black women
had 38 total deaths (45 %) with 10 (26 %) deaths due to cancer.

65

Table 15
Vital Statistics for Charleston Heart Study*
1974175-1994
All

Cancer
Deaths

N

Deaths

300
129
66
495

179
81
26
286

42
21
69

121
48
40
209

White Women
Black Women

319
84
403

114
38
152

29
10
39

205
46
251

Total

898

438

108

460

White Men
Black Men
High SES Black Men

§

Alive

*Includes only subjects who had serum DDE measured in 1974/75

Lung cancer was the most frequent cancer site observed among both men and women,
as noted in Table 16. Lung cancer accounted for 9 % of all deaths and 36 % of all cancer
deaths. The second most frequent cancer site was the digestive tract which included cancer
of the esophagus, stomach, colon, gall bladder and pancreas. These cancers accounted for 6
% of all deaths and 25 % of all cancer deaths. There were

5 leukemia deaths and 4 lymphatic

cancer deaths, both groups together accounted for about 2 % of all deaths and 8 % of all
cancer deaths. There were 17 hormone-related cancers with 8 prostate, 7 breast, 1 ovarian
and 1 uterine. Taken together, the honnone-related cancers accounted for about 4 % of all
deaths and 16 % of cancer deaths.
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Table 16
Distribution of Cancer Deaths by Site
Cancer Site
Total Deaths
Lung (162)
39
Digestive (150-159)
25
9
Lymphatic & Leukemia (200-208)
Honnone-Related (174,179,183,185)
17
18
Other*
Total

108

Men
26
17
5
9
12

Women
13
8
4
8
6

69

39

* Two or fewer deaths per site

The standardized mortality ratio, SMR, was computed with the U.S. population as the
external comparison group. The SMR was used to detennine whether the CHS cohort
experienced the same cancer mortality pattern as the standard population. Because the eRS
had higher levels ofDDE, as reported in a previous section, there was concern that a bias
may have been introduced which would obscure any increased risk of cancer mortality
associated with high exposure levels. The SMR addressed this concern by providing an
external comparison. This estimate was adjusted for age in groups of five years beginning
with age 35 ( 35-39, 40-44, 45-49, 50.. 54, 55-59, 60-64, 65-69, 70-74, 75-79, ::s..80) and also
for calendar year in five-year intervals beginning with 1974 (1974-1979, 1980-1984, 19851989, 1990-1994). The expected and observed rates are included in Appendix C.
Although there was a slight increase in the number of total cancer deaths for this
cohort compared to that expected in the U.S., the difference was not statistically significant.
The SMR adjusted for age and calendar year was 1.07 (95% CI: 0.97, 1.16).
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Frequency of Reported Use

The analyses of self-reported data, were restricted to those for whom DDT
measurements were made in 1974/75. The frequency of self-reported use of pesticides for
each race-sex group is in Table 17. The first half of the table shows the frequency of those
who reported ever using pesticides. There were 258 (29 %) participants who reported not
ever using pesticides and 638 (71 %) who reported some use. There was a statistically

Table 17
Frequency Table of Reported Use of Pesticide Stratified By Race-Sex Group

R ace-S ex G roup
White
Black
Black
Women
Women
Men

Reported
Pesticide Use*

White
Men

High SES
Black Men

Total

No

73

83

50

24

28

258

Yes

227

234

79

60

38

638

Total

300

317

129

84

66

896

..

X~-16.2, p=0.003

* Answered yes to any of the three pestIcIde questIons

Race-Sex G roup
Black
White
Black
Women
Women
Men

Reported
DDTUse*

White
Men

High SES
Black Men

Total

No

91

37

14

5

3

152

Yes

203

276

100

79

54

712

Total

294

313

114

84

57

864

*Answered yes to the question re garding exp osure to DDT

~=62.3 ,p- 0.001
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significant difference in reported pesticide use by race and gender. The most frequent users
of pesticides were the white men with 227 (76%) giving a positive response. The second
most frequent users were white women with 234 (74 %) reporting pesticide use. Black
subj ects reported slightly less use, and the high SES black reported the lowest use, with 38
out of 66 (58 %).
The second half of the table shows the self reported use of DDT. There was a
statistically significant difference in DDT use by race and gender. There were 152
(18 %) who reported an experience of DDT exposure, while a much larger group, 712
(82 %), reported no exposure to DDT. Among the white men, 93 (31 %) reported using
DDT, while 37 (13 %) white women, 14 (12 %) black men,S (6 %) black women and 3
(5 %) of the high SES black men reported specific DDT use.

Confounding: Reported Use and Cancer Mortality
To investigate the potential existence of confounding variables, univariate descriptive
statistics for selected variables were examined across the exposure levels. The variables
chosen were putative cancer risk factors for which data were available in the cohort.
Table 18 contains the comparison of these potential confounding variables by selfreported pesticide usage. The statistical significance was determined from two methods: one
was based on the unadjusted value from pooled t-tests or chi-square analysis, and the second
was from logistic regression models adjusting for age, gender and sex. The risk factors
which were statistically significant between exposure groups were race and education; with
more whites reporting use compared to blacks and more pesticide use associated with higher
education. After adjusting for age, race and gender, however, the p-value for education
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increased to 0.25, becoming non-statistically significant. There was marginal significance for
smoking in the unadjusted case which became non-significant after adjustment. Also, after
adjustment for age, race and gender, BMI became borderline statistically significant with a pvalue of 0.06. This suggested a larger BMI was associated with reporting of pesticide usage.
There was no difference among the exposure groups for cholesterol levels.

Table 18
Comparison of Putative Risk Factors with Reported Use of Pesticides
Cancer Deaths
Yes No
Age (mean years)
Gender (% male)
Race (% white)
Smoking (% smokers)
Education (mean years)
BMI (mean kg/m2)
Cholesterol (mean mg/dl)

60.0 60.0
58.5 53.9
60.5 72.3
38.8 32.6
9.4 10.0
25.7 26.1
242.8 242.5

p-value8

p-valueb

0.97
0.21
0.01
0.08
0.05
0.19
0.93

0.11
0.25
0.06
0.63

p-value derived from pooled t-test or chi-square analysis
b Adjusted for age, race and gender
a

These same potential covariates were also tested to determine if they were associated
with an increased risk for cancer. Table 19 indicated an increasing age, male sex and
cigarette smoking as risk factors for cancer mortality in this cohort with serum DDT
measurements. After adjusting for age, race and gender, smoking retained its statistical
significance. Both education and body mass index were not found to be significant risk
factors for this cohort, either before or after adjustment. Cholesterol reached borderline
statistical significance before adjustment of the covariates and the p-value decreased further
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after adjustment. This suggested that those with lower cholesterol had an increased risk for
cancer. Thus, based upon the results in Tables 18 and 19, race was the only variable found to
be a confounder between reported pesticide use and cancer mortality in this cohort.

Table 19
Cancer Deaths and Possible Risk Factors
For Subjects with DDT Measurements
Cancer Deaths
Yes No
Age (mean years)
Gender (% male)
Race (% white)
Smoking (% smokers)
Education (mean years)
BMI (mean kglm2)
Cholesterol (mean mgldl)

62.7 59.6
64.5 54.0
65.4 69.3
50.9 32.0
9.8
9.5
25.5 26.0
234.6 243.7

p-value8

p-value b

0.02
0.04
0.35
0.01
0.52
0.34
0.07

0.01
0.84
0.34
0.06

p-value derived from pooled t-test or chi-square analysis
b Adjusted for age, race and gender

a

Self Reported Use and Cancer Mortality
Of those who died of cancer, 26% answered "no" to all three questions concerning
pesticide use while 74% answered "yes" to at least one question, as noted in the top portion
of Table 20. Overall, 638 (71 %) subjects reported some use of pesticides. The crude RR,
was 1.14, suggesting a 14 % increased risk of cancer associated with reported use of
pesticides. The latter part of Table 20 gives the results obtained from the question regarding
DDT exposure. Overall, only 152 (17 %) answered "yes" to the question regarding DDT
and of those dying of cancer, 20 (19 %) replied "yes" and 85 (80 %) replied "no". The crude
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RR for this data was 1.10, also suggesting a slight increased risk of cancer mortality
associated with a reported history of DDT.

Table 20
Self-Reported Use of Pesticide and Cancer Mortality
Cancer Death
Reported
Pesticide Use*
No

No
230

Yes
28

Total
258

Yes

559

79

638

Total

789

107

896
RR = 1.14

* Answered yes to any of the three pesticide questions
Cancer Death
Reported
DDTUse*
No

No
627

Yes
85

Total
712

Yes

132

20

152

Total

759

105

864
RR = 1.10

*Answered yes to the question regarding exposure to DDT

Table 21 contains the results from several Cox proportional hazards (PH) regression
models with reported pesticide use defined as yes to any of the three questions. Models were
constructed for the total sample and also stratified by gender. Some models adjusted only for
the effect of race, which was found to be a confounder, and other models adjusted for the
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additional factors of age, smoking, BMI, education and cholesterol. The first model adjusted
for race only and yielded a non-statistically significant RR of 1.10 (CI: 0.72, 1.70); adding

Table 21
Relative Risks for All Cancer Mortality and Reported Pesticide Use*

cases
Reported Use
No
Yes

28
79

person-years

RRa (9S% CI)

RRb (9S% CI)

3894
9998

1.00
1.10 (0.72, 1.70)

1.00
1.25 (0.80, 1.9S)

RRa (9S% CI)

RRC(95% CI)

2114
S020

1.00
1.34 (0.76, 2.36)

1.00
1.54 (0.86, 2.75)

person-years

RRa (95% CI)

RRC(95% CI)

1781
4978

1.00
0.78 (0.40, I.S4)

1.00
0.75 (0.37, 1.50)

Men
cases person-years
Reported Use
No
Yes

16
53

Women
cases
Reported Use
No
Yes

12
26

* Answered yes to any question regarding pesticide use in 1974/75

Adjusted for race
b Adjusted for age, smoking, race, gender, BMI, cholesterol, education
C Adjusted for age, smoking, race, BMI, cholesterol, education
a

other risk variables slightly increased the estimate of the relative risk to 1.25 (CI: 0.80, 1.95).
For gender specific models, men showed over a 30 % increased risk of cancer mortality for
past pesticide use compared to those reporting no use. However, the increased risk was not
statistically significant (RR= 1.34, CI: 0.76, 2.36). For women there was no association of
cancer mortality with DDT using the self-reported data for either model.
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Table 22 gives the results from Cox PH Regression with the exposure defined as selfreported DDT use. The RR was 1.09 eCI: 0.66,1.74) for the model adjusting for age only and
decreased in the fully adjusted model, thus suggesting no association of reported use of DDT
and cancer mortality. In the gender specific analyses, there were 17 men who died of cancer
and reported a positive use of DDT and 50 men who died of cancer and reported no use of
DDT. The risk estimates for both models were near 1.00, indicating no association. For the
women, out of the 38 women who died of cancer, only 3 reported a positive history of DDT
usage and the risk estimates also suggested no association of DDT usage and cancer
mortality.

Summary o/Self-Reported Use and Cancer Mortality
In summary, there was no evidence to support an increased risk of cancer mortality
with reported pesticide usage. This finding was confinned for pesticide use in general and
for DDT specifically. Adjustment for the confounder race as well as adjustment for other
cancer risk factors did not alter these findings.
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Table 22
Relative Risks for All Cancer Mortality and Reported Pesticide Use*

person-years

RRa (95% CI)

RRb (95% CI)

10951
2439

1.00
1.09 (0.67, 1.79)

1.00
1.04 (0.63, 1.73)

cases person-years

RRa (95% CI)

RRC(95% CI)

50
17

5017
1680

1.00
1.00 (0.57, 1.77)

1.00
1.07 (0.66, 1.91)

person-years

RRa (95% CI)

RRC(95% CI)

5934
759

1.00
0.68 (0.21, 2.23)

1.00
0.72 (0.22,2.36)

cases
Reported Exposure
No
Yes

85
20

Men
Reported Exposure
No
Yes

Women
cases
Reported Exposure
No
Yes

35
3

• Answered yes to any question regarding exposed to DDT in 1974/75
a Adjusted for age
b Adjusted for age, smoking, race, gender, BMI, cholesterol, education
C Adjusted for age, smoking, race, BMI, cholesterol, education

Mean Levels o/Serum DDE
The mean serum level ofDDE for the 898 participants was 36.7 ppb with a standard
deviation of 27.9 ppb. The highest levels occurred among black men, who had an average
59.27 ppb followed by black women (47.20 ppb), white men (32.61 ppb) and white women
(27.68 ppb). The differences in DDE levels among the four race-sex groups was statistically
significant (p < 0.1).
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Confounding: Serum DDE and Cancer Mortality

Table 23 contains a comparison of putative risk factors across DDE tertile levels. As
noted in this table DDE levels increased with age, and higher levels were noted in blacks
compared to whites and in men compared to women. After adjusting for age, race, and
gender, there was no linear trend for smoking status or levels ofBMI. However, those with
higher cholesterol and lower education had higher levels ofDDE.

Table 23
Comparison of Putative Risk Factors by Serum DDE Tertiles

Age (mean, years)
Race (% White)
Sex (% Male)
Smoking (% yes)
Cholesterol (mean, mgldl)
Education (mean, years)
BMI (mean, kglm2)

Tertilel
(0.5.24)

DDE Tertiles*
Tertile 3
Tertile 2
( >39)
(25.39)

o-valuea

59.5
86.2
42.0
31.7
240.1
10.5
26.0

59.6
71.5
61.0
37.3
244.8
10.1
26.0

0.05
0.01
0.01
0.35
0.54
0.01
0.20

60.8
47.8
63.2
34.0
242.4
8.8
26.9

t>-valueb

0.87
0.05
0.05
0.76

* Serum p,p'DDE measured in parts per billion
Test for trend using logistic and linear regression
b Adjusted for age, gender and race
a

These same covariates were compared for men and women separately and the results
are shown in Table 24. DOE levels were increased in blacks compared to whites for both
men and women. For women, ODE levels were increased with age and inversely related to
serum cholesterol levels. Among men, DOE levels were decreased with educational
attainment.
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Table 24
Comparison of Putative Risk Factors by Serum nnE Tertiles

nnE Tertiles
Men
Age (mean, years)
Race (% White)
Smoking (0/0 yes)
Cholesterol (mean, mg/dl)
Education (mean, years)
BMI (mean, kg/m2)

Tertilel
(0.5,27)
59.9
78.8
36.4
232.8
10.9
25.6

Tertile 2
(28,41)
60.0
65.9
46.2
235.2
10.1
25.8

Tertile 3
(> 41)
59.6
35.7
42.7
233.6
8.7
26.3

p-value8
0.76
0.01
0.88
0.85
0.01
0.20

Tertilel
(0.5,20)
58.8
91.9
30.4
247.6
10.4
25.9

Tertile 2
(21,34)
59.6
83.6
26.1
253.7
9.8
26.1

Tertile3
( >34)
62.0
61.9
18.7
258.7
8.8
26.5

p-value8
0.01
0.01
0.03
0.05
0.01
0.35

p-value b

0.89
0.33
0.01
0.22

Women

Age (mean, years)
Race (0/0 White)
Smoking (0/0 yes)
Cholesterol (mean, mg/dl)
Education (mean, years)
BMI (mean, kg/m 2)

a
b

p-valueb

0.53
0.10
0.34
0.19

Test for trend using logistic and linear regression
Adjusted for age and race

These potential covariates were also examined to determine if they were associated
with an increased risk for cancer mortality. Table 25 indicated male sex and an increasing
age were found to be risk factors for cancer mortality in this cohort. After adjusting for age,
race and gender, smoking was also a risk factor for cancer mortality, while education and
BMI were not found to be significant risk factors. Those with lower cholesterol were at an
increased risk for cancer mortality; however, this p-value increased after adjustment for age,
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race and gender. (This table was similar to the findings in Table 19 which considered the
covariates as related to cancer morality for reported usage of pesticides, instead of serwn
measurements. Slight differences were due to the number of subjects: there were 898 subjects
in this analysis and only 896 for the previous analysis.)

Table 25
Cancer Deaths and Possible Risk Factors

Cancer Deaths
Yes
No
Age (mean years)
Gender (% male)
Race (% white)
Smoking (% smokers)
Education (mean years)
BMI (mean kg/m2)
Cholesterol (mean mg/dl)

62.8
63.9
65.7
50.9
9.6

26.1
234.6

59.6
53.9
69.4
32.0
9.8
25.5
243.7

o-valuea
0.01
0.05
0.37
0.01
0.51
0.35
0.05

o-valueb

0.01
0.67
0.48
0.06

a p-value

derived from pooled t-test or chi .. square analysis
b Adjusted for age, gender and race

In summary, examination of the results in from Tables 24 and 25 reveal the only

variables as potential confounders for DDE levels and cancer mortality in this cohort to be
age and gender. Thus, subsequent analyses were adjusted for age stratified by gender.

Standardized Mortality Ratio

Table 26 contains the cancer mortality rate observed over the twenty-year period
stratified by the baseline age groups. For each of the five age groups, the number of observed
deaths was calculated from the entire cohort and by tertile level ofDDE. No increased rate of
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mortality was observed across DDE tertiles when examined by age strata. It is interesting to
note that overall the higher mortality rates were observed in the middle tertile group. This
finding was also observed in all age groups with the exception of the two youngest.
Standardized Mortality Ratios were computed for cancer mortality by DDE tertiles,
age group and calendar year (See Appendix D). The SMRs centered around 1.0, indicating
no difference of cancer death rate for this cohort compared to the standard u.s. rates
stratified for age and calendar year. Table 27 contains a summary from the SMRs for DDE
tertiles by age group and calendar year. The SMR for the first and third tertiles were below
1.00 (or under 100 %) while the second tertile was above 1.00. The rate ratios were
computed using the ratio of SMRs, which will be discussed further in the next section. Both
the test for homogeneity and trend were not statistically significant. These data do not
provide evidence for an increasing dose-response trend of mortality with DDE category.
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TABLE 26
Cancer Death Ratea for Charleston Heart Study
by DDE Tertiles and AGE
DDE
AGE
1974/75

Tertile 1
Tertile3
Tertile 2
(0.5-24 ppb) (25-39 ppb) (> 39 ppb)

TOTAL
=898

35-44

observed
0
person-years 41.82
0
rate *

0
41.82
0

1
102.86
972.19

1
186.5
536.19

45-54

observed
5
person-years 1982.74
rate
252.18

4
1640.37
243.85

5
1344.91
371.77

14
4968.02
281.802

55-64

observed
person-years
rate

16
1958.14
817.10

23
1807.85
1272.23

11
1774.34
619.95

50
5540.33
902.47

65-74

observed
person-years
rate

12
944.06
1271.11

11
790.17
1392.11

14
1034.78
1352.24

37
2769.01
1336.22

75>

observed
person-years
rate

1
180.49
554.05

3
112.07
2676.90

2
171.03
1169.39

6
463.59
1294.25

TOTAL

observed
person-years
rate

34
5107.25
665.72

41
4392.28
933.46

33
4428.46
745.18

108
13927.45
775.45

* rate per 100,000 person-years
a

ICD Codes: 140.0 - 239.9 (excluding benign neoplasms)
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Table 27
Summary Table of Standardized Mortality Analysis of DDE Tertiles
Adjusted for age and calendar year

Tertile 1

DDE
Tertile 2

Number of observed deaths
34
Person-Years
5376
Rate( per 100,000)
632.5
Expected deaths (adjusted for age and calendar year) 37.0
93.6
SMR (%)
1.00
RR (ratio of SMR)

41
4613
88.7
30.6
134.0
1.43

Test of homogeneity
Test of trend

Tertile 3
33
4623
713.7
33.1
99.7
1.06

2
X 2= 3.02; p-value =0.22
2
X ]= 2.81; p-value =0.09

Comparison of Estimates ofRelative Risks
A number of different statistical methods was used to obtain the relative risk of cancer
mortality. These included the standardized mortality analysis using an external comparison
group and Poisson and Cox Regression for the multivariable analysis. For both of the
regression models the number of expected deaths was assumed to be unknown. Table 28
gives a summary of the results from these methods. There were 34 cancer deaths in the
lowest level of DDE, 41 deaths in the second tertile and 33 in the highest tertile. The first
model, labeled as RRa , gives the estimates from Cox PH models adjusted for age only. The
RR for those in the second tertile was 1.46 compared to those in the first tertile, whereas
those in the third tertile had a RR of 1.05 compared to those in the first. The p-value for
trend was not statistically significant (p=O.58). The results in the second model were
computed from the ratio of SMRs using maximum likelihood procedures to estimate the
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confidence intervals. The results in the third model labeled as RR c, were computed from
Poisson regression models using person-years as the rate denominator. The final model, RRd,
used Poisson regression where the expected values were derived from the U.S. popUlation for
an external standard in the rate denominator. The results for all of these models suggest no
increase in risk of cancer mortality with increasing DDE levels. Because the risk estimates
from the various tests were similar, subsequent analyses were performed only with Cox
proportional hazards regression.

Table 28
Comparison of Estimates Using Rate Standardization
and Multivariate Analysis

Combined Tertiles
RRb

cases
DDE Tertiles
1
2

3

34
41
33

1.00
1.457
1.047

1.00
1.454
1.060

1.00
1.484
1.085

1.00
1.465
1.065

aUsing Cox Proportional Hazard Regression adjusting for age
b Using Standardized Mortality Ratio adjusting for age and calendar year
C Using Poisson Regression with an internal rate denominator adjusting for age and calendar year
dUsing Poisson Regression with an external rate denominator adjusting for age and calendar year

DDE and Cancer Associations
Table 29 contains the results from Cox regression models with the exposure variable
in the form of tertiles, quartiles and quintiles. Results from all three analyses showed a slight
increased risk for those in the middle categories and a decreased risk for those in the highest
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category levels. Interestingly, a statistically significant increased risk was observed in the
third quartile of DDE.

Table 29
Relative Risk of Cancer Mortality Based on Various Categories of DDE Exposure
a

No. Cases

Variable

Combined Sample (n=898)
Tertile DDE
1
34
2
41
3
33

p-value

RR(CI)

0.13
0.61

1.000
.422 (0.902, 2.240)
1.133 (0.702, 1.829)

0.46
0.01
0.96

1.000
1.228 (0.713,2.117)
1.975 (1.181, 3.300)
1.013 (0.567, 1.810)

0.82
0.33
0.25
0.73

1.000
0.933 (0.509, 1.710)
1.326 (0.748, 2.352)
1.408 (0.789,2.512)
0.896 (0.476, 1.688)

Quartile DDE
25
27
35
21

1
2

3
4

Quintile DDE
1
2

3
4

5
a Unadjusted

22
20
25
24
17

RR derived from Cox PH Regression

The analysis was repeated stratified by gender and the results are shown in Tables 30a
and 30b; again the estimates followed the same pattern with the middle groups having larger
risk estimates than the lower and upper groups. The statistical significance shown in the third
quartile for all subjects diminished when stratified by gender. Because of the small sample
size for the quartile and quintile groups, and since the same patterns were observed for each
choice of categorization, subsequent models used only tertile designations.
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size for the quartile and quintile groups, and since the same patterns were observed for each
choice of categorization, subsequent models used only tertile designations.

Table 30a
Relative Risk of Cancer Mortality Based on Various Categories of DDE Exposure
By Gender
8

Men

cases

Tertile DDE
1
2
3

20
30
19

Quartile DDE
1
2
3
4

Quintile DDE
1
2
3
4

5
a Unadjusted

12
22
21
14

8
15
21
13
12

~-value

RR(CI)

0.13
0.93

1.000
1.546 (0.878, 2.723)
1.027 (0.548, 1.924)

0.11
0.11
0.68

1.000
1.767 (0.875, 3.571)
1.771 (0.871, 3.600)
1.173 (0.543, 2.537)

0.11
0.02
0.20
0.36

1.000
2.001 (0.848, 4.721)
2.660 (1.178, 6.007)
1.737 (0.741, 4.312)
1.516 (0.620, 3.709)

RR derived from, Cox PH Regression
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Table 30b
Relative Risk of Cancer Mortality Based on Various Categories of DDE Exposure
By Gender
8

Women
Tertile DDE
1
2
3

16
10
13

Quartile DOE
1
2
3
4

8
12
10
9

Quintile DOE
1
2
3
4

5
a Unadjusted

5
12
8
7
7

0.29
0.77

1.000
0.655 (0.297, 1.442)
0.895 (0.430, 1.860)

0.46
0.05
0.83

1.000
1.405 (0.574, 3.437)
1.319 (1.181, 3.342)
1.112 (0.429, 2.882)

0.08
0.61
0.42
0.71

1.000
2.504 (0.882, 7.108)
1.331 (0.435, 4.070)
1.601 (0.508, 5.047)
1.246 (0.395, 3.926)

RR derived from Cox PH Regression

To examine 'Ute effect of tertile categories on the RR, analyses were conducted with
various cutpoints used to define the tertiles. In Tables 31 a, 31 b, and 31 c, results from Cox
models are shown for the different race-sex groups. The first part, Table 31 a, contains the
estimates from the entire cohort with the cutpoints of DOE determined from the entire cohort.
The second set of analyses, Table 31 b, were performed with race-sex specific terti Ie
cutpoints, while the last part of the table, Table 31 c, shows the results using gender specific
cutpoints. Examination of results from all of the analyses, confirmed the lack of any trend or
statistical association regardless of the specific tertile definition.
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Table 31a
Relative Risk of Cancer Mortality Using Various Tertile Definitions ofDDE·
Tertile Cutpoints derived from DDE distribution for all subjects

All Subjects

Tertile 1
2
3

Cutpoints
(0.5, 24)
(25, 39 )
(> 35 )

White Men

Tertile 1
2
3

(0.5, 24)
(25, 39 )
( > 39)

1.000
1.827(0.904, 3.694)
0.974(0.398, 2.384)

White Women

Tertile 1
2
3

(0.5, 24)
(25, 39 )
( > 39)

1.000
0.831(0.337, 1.961)
0.771(0.284, 2.090)

Black Men

Tertile 1
2
3

(0.5, 24)
(25, 39 )
( > 39)

1.000
0.951(0.184,4.903)
1.241(0.282, 5.465)

Black Women

Tertile 1

(0.5, 24)
(25, 39 )
( > 39)

1.000
0.668(0.135,3.321)
0.532(0.119, 2.379)

(0.5, 24)
(25, 39 )
( > 39)

1.000

2

3
High SES Black Men

Tertile 1
2

3

* Serum DDE measured in parts per billion

RR(95% CI)
1.000
1.422(0.902, 2.241)
1.133(0.702, 1.829)
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Table 3tb
Relative Risk of Cancer Mortality Using Various Tertile Definitions ofDDE*
Tertile Cutpoints derived from DDE distribution from each race-sex group
Cutpoints

RR(95% el)

White Men

Tertile 1
2
3

(0.5, 24)
(25, 37 )
( > 37 )

1.000
1.808(0.877, 3.727)
1.128(0.498, 2.558)

White Women

Tertile 1
2
3

(0.5, 19)
(20, 30 )
( > 30)

1.000
0.520(0.210, 1.289)
0.655(0.275, 1.562)

Black Men

Tertile 1
2
3

(0.5, 37)
(38, 58 )
( > 58)

1.000
1.189(0.417,3.393)
1.184(0.415,3.379)

Black Women

Tertile 1
2
3

(0.5, 33)
(34, 47 )
( > 47)

1.000
2.139(0.570, 8.024)
0.286(0.032, 2.561)

High SES Black Men

Tertile 1
2
3

(0.5, 31)
(32, 44 )
( > 44)

1.000
1.868(0.312, 11.184)
0.526(0.048, 5.800)

* Serum DDE measured in parts per billion
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Table 31c
Relative Risk of Cancer Mortality Using Various Tertile Definitions ofDDE*
Tertile Cutpoints derived from DDE distribution for gender groups
Cutpoints

RR(95% CI)

All Men

Tertile 1
2
3

(0.5,27)
(28, 41 )
( > 41 )

1.000
1.546(0.878, 2.723)
1.076(0.579, 2.000)

White Men

Tertile 1
2
3

(0.5, 27)
(28,41 )
( > 41 )

1.000
1.738(0.913, 3.310)
0.570(0.190, 1.704)

Black Men

Tertile 1
2
3

(0.5,27)
(28,41 )
( > 41 )

1.000
0.849(0.202; 3.562)
1.086(0.309, 3.817)

High SES Black Men

Tertile 1
2
3

(0.5, 27)
(28,41 )
( > 41 )

1.000
2.277(0.237, 21.891)
1.354(0.123, 14.939)

All Women

Tertile 1
2
3

(0.5, 20)
(21, 34 )
( > 34)

1.000
0.655(0.297, 1.442)
0.895(0.430, 1.860)

White Women

Tertile 1
2
3

(0.5,20)
(21, 34 )
( > 35 )

1.000
0.663(0.278, 1.581)
0.815(0.329,2.020)

Black Women

Tertile 1
2
3

(0.5,20)
(21,34 )
( > 34 )

1.000
0.510(0.072, 3.627)
0.739(0.149,3.671)

* Serum DDE measured in parts per billion
Because age and gender were the only variables that were significant risk factors for
cancer and also associated with DDE levels, subsequent analyses controlled for their effects.
The proportional hazards models were adjusted for age and stratified by gender. Other
models contained additional risk variables of smoking, BMI, cholesterol and education.
Table 32 gives the results from the two Cox models using tertile determinations based upon
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Table 32
Relative Risks for All Cancer Mortality
Combined Tertiles
cases
DDE Tertiles
1
2
3

34
41
33

Gender Specific Tertiles
Men
cases
DDE Tertiles
14
1
2
31
24
3

person-years RRa (95% CI)

RRb (95% CI)

5107
4392
4428

1.00
1.32 (0.82, 2.12)
0.96 (0.57, 1.61)

1.00
1.46 (0.92, 2.30)
1.05 (0.65, 1.70)

person-years RRa (95% CI)
1981.45
2513.80
2637.97

RRC(95% CI)

1.00
1.00
1.534 (0.871, 2.702) 1.623 (0.908, 2.900)
1.041 (0.556, 1.951) 1.133 (0.573, 2.241)

Women
cases
DDE Tertiles
1
2
3

20
10
9

person-years RRa(95% CI)
3125.31
1878.32
1789.66

RRC(95% CI)

1.00
1.00
0.607 (0.274, 1.343) 0.564 (0.251, 1.271)
0.727 (0.346, 1.530) 0.629 (0.275, 1.440)

Adjusted for age
b Adjusted for age, smoking, race, gender, BMI, cholesterol, education
C Adjusted for age, smoking, race, BMI, cholesterol, education
a

the distribution from the total cohort~ The first model shows the results from age-adjusted
models while the second models show the results adjusted for additional covariates. The risk
estimates decreased after the addition of the covariables. The RR was 1.32 (CI: 0.82, 2.12)
for those in the second tertile compared to those in the first, while the RR was 0.96 (CI: 0.57,
1.61) for those in the third tertile compared to those in the first. This suggested no increasing
risk of cancer mortality associated with increasing levels of DDE.
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The statistical analysis was repeated using the gender specific cutpoints and the
results are shown in the bottom portion of Table 32. The risk estimates for the men in the
first model adjusting for age only were similar to the estimates computed from the total
cohort. There was a 50 % increase in the risk of cancer mortality for those in the second

.

tertile compared to those in the first and a 4 % increase in risk for those in the highest tertile;
however, this trend was not statistically significant. (Recall that the same pattern existed with
the combined group, the estimates in the highest tertile were decreased from the estimates in
the second.) The fully adjusted model yielded slightly larger estimates than those from the
age-adjusted model only; this was different than that found in the combined group in which
adding other risk factors yielded smaller estimates. In summary, the results for men indicated
no association between cancer mortality and increasing levels ofDDE.
Among the women, there were 20 cancer deaths in the lowest levels ofDDE, 10 in
the second tertile and 9 in the third tertile. For the model adjusting for age only, the risk
estimates decreased in the second tertile, and there was a slight increase in the third tertile,
For both tertile groups, the estimates were under 1.0 and the confidence intervals were
centered around 1.0, suggesting no association between DDE levels and cancer mortality.
The risk

e~timates

decreased further when additional covariates were included.

Other analyses considered DDE as a continuous variable. Linear, quadratic and cubic
terms for DDE were included in the Cox proportional hazard regression model to investigate
a possible curvilinear relationship between DDE levels and cancer mortality. These results
are shown in Table 33. The quadratic coefficient in the models was negative; thus suggesting
an inverted u-shape relationship between DDE and cancer mortality. This finding was
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Table 33
Cox Proportional Hazards Regression a Coefficients
for Association between DDT and Cancer Mortality
Combined Sample

Cubic Model
Linear
Quadratic
Cubic
Quadratic Model
Linear
Quadratic
Linear Model
Linear

Coefficient

p-value

0.006622
-0.000551
-0.0000043

0.5025
0.1260
0.6814

0.003665
-0.000502

0.5986
0.0180

-0.007579

0.0992

Gender Specific

Cubic Model
Linear
Quadratic
Cubic
Quadratic Model
Linear
Quadratic
Linear Model
Linear

Men (n=495)
Coefficient
p-valueb

Women (n=403)
Coefficient p-valueb

0.017966
-0.000463
-0.0000105

0.1768
0.2382
0.4173

-0.007776
-0.000957
..0.000003

0.6856
0.2108
0.9268

0.009335
-·0.000668

0.2896
0.0298

-0.009072
-0.000994

0.4911
0.1266

-0.005974

0.2493

..0.016900

0.1048

---------------------------------------------------------adjusted for age, gender, race, smoking, BMI, cholesterol, education
a

b adjusted

for age, race, smoking, BMI, cholesterol, education

consistent with the previous analyses using tertiles ofDDE where the relative risk was
elevated for those in the middle tertile and decreased for those in the highest tertile as
compared to the lowest tertile. There was a significant quadratic association (p < 0.05) for the
total cohort and for men. While the linear trend in the total sample and for the women
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approached statistical significance (p=0.1 0), the coefficient was negative for both cases and
hence did not support the hypothesis ofa positive association between DDE levels and cancer
mortality.
The graph in Table 34 shows the hazard ratio over the range of DDT levels for the
quadratic regression model. The mean DDE level for the total cohort was 36.7 ppb, which
was used as the reference point and the corresponding RR was 1.00. The graph depicts an
inverted u-shaped relationship between DDE levels and cancer mortality. The maximum
relative risk estimate, 1.01, occurs at the centered value of 3.3, which corresponds to 40 ppb
ofDDE.

Table 34
Quadratic Regression
1.2
1

0 0.8
~

~
C 0.6
0::

~

:J:

0.4
0.2
0
-36 -30 -23 -16 -8.7 -1.7 5.3 12.3 19.3 26.3 33.3 40.3 47.3 54.3 61.3 68.3 75.3 82.3 89.3 96.3

(DDE-36.7)
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Site Specific Analysis
Site specific analyses using Cox PH models were conducted for lung, digestive,
lymphatic and leukemia, and hormone-related cancers. The results of these analyses are
presented in Table 35. Because of the small number of events, no gender specific analyses
were performed.
For lung cancer mortality, there was an apparent increased risk across DDE levels.
The RR was 1.3 in both of the two upper tertiles compared to the lowest tertile. However,
this slight upward trend was not statistically significant. Adding other risk variables
(education, BMI, race, gender, cholesterol, and smoking) increased the estimates; however,
the increase was not enough to reach conventional statistical significance and the test for
trend was not statistically significant (p=0.49). The results for the digestive cancers were
similar to the results for all cancer mortality. That is, the risk estimate increased in the
second tertile (RR=2.3; CI: 0.88, 6.2) and then decreased in the third tertile (RR=I.25; CI:
0.42,3.7). There was no statistical significance observed for either model. The numbers
were very small in the leukemia and lymphatic groups, 3 cancer deaths in the first tertile, 5 in
the second tertile, and only 1 in the third tertile. Again, the same pattern was observed where
the risk estimates increased in the second tertile and then decreased in the third tertile group.
For hormone-related cancers there was an increased risk ofmortaIity associated with
increasing levels of DDE. The RR was 1.03 in the second tertile and 1.7 in the third. The test
for linear trend was not statistically significant (p=0.69) and the confidence intervals for the
relative risks all included 1.0. Thus no significant association of increased cancer mortality
for the specified sites and higher levels ofDDE was observed in this cohort for any of the
specific types of cancer analyzed.
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TABLE 35
Site Specific Analyses with DDE Tertiles
Combined Cutpoints

Relative Risks for Lung Cancer Mortality
cases

RRa (95% CI)

RRb (95% CI)

1.00
1.29 (0.59, 2.83)
1.31 (0.61, 2.85)

1.00
1.31 (0.58, 2.94)
1.65 (0.73,3.75)

DDE Tertiles
1
2

3

12
13
14

Relative Risks for Digestive Cancer Mortality
cases

RRa (95% CI)

RRb (95% CI)

1.00
2.34 (0.88, 6.23)
1.25 (0.42, 3.74)

1.00
1.71 (0.62,4.75)
0.75 (0.23,2.42)

DDE Tertiles
1
2

3

6
12
7

Relative Risks for Lymphatic & Leukemia Mortality
cases
DDE Tertiles
1
2
3

3
5
1

RRa (95% CI)

RRb (95% CI)

1.00
2.15 (0.51, 9.01)
0.36 (0.04, 3.48)

1.00
2.54 (0.53, 12.13)
0.44 (0.040,4.73)

Relative Risks for Hormone-Related Cancer Mortality
cases
DDE Tertiles
1
2
3

5
4
8

RR8 (95% CI)

RRb (95t}'o CI)

1.00
1.03 (0.28, 3.84)
1.67 (0.55, 5.11)

1.00
0.62 (0.14, 2.68)
1.18 (0.35, 4.02)

Cox regression models adjusted for age
b Adjusted for age, smoking, race, gender, BMI, cholesterol, education

a
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Actual versus Reported Use

The mean serum level ofp,p'DDE of those who reported using pesticides was
compared to those who reported no use. As noted in Table 36, in all race-gender groups,
except the high SES black men, there were similar serum DDE values for those reporting
some previous pesticide use compared to those reporting no previous use. These results

Table 36
Reported Pesticide Use* versus Serum ODE Levels
By Race-Gender Groups
Mean (± sd) Serum Level ofp'pDDE

White
Male

White
Female

Black
Male

Black
Female

HSES Black

27.16 (19.08)
27.91 (16.29)
0.73

64.78 (52.66)
55.79 (31.80)
0.28

48.92 (24.23)
46.52 (40.86)
0.74

31.86 (11.98)
49.82 (35.57)
0.01

Male

Use

NO 32.05 (19.42)
YES 32.69 (19.47)
p-value

0.81

White

By race groups
Black

USES Black

Reported Use

NO
YES
p-vaule

29.45 (19.33)
30.26 (18.07)
0.63

59.63 (45.85)
51.78 (36.15)
0.20

31.86(11.98)
49.82 (35.57)
0.01

By gender groups
Male
Female
Reported Use
NO

YES
p-value

42.85 (36.78)
39.88 (26.83)
0.37

*Answered yes to any of the three questions asked in 1974/75

32.04 (22.19)
31.71 (24.57)
0.90
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suggest that self-reported exposure data was not a very good surrogate for exposure in this
cohort. For valid analyses of exposure based on self-report, there should have been a greater
serum DDE values among those who reported a positive usage of DDT. This was not the
case.

Specific Aim 3
To test the hypothesis that there is increased risk of breast and prostate cancer
associated with increasing levels of ODE

Vital Statistics and Cancer History
Table 37 contains the number of cancer incidence cases occurring dwing the twentyyear follow-up, 1974-1994. Twenty-one women developed breast cancer, 18 white women
and 3 black women, while 28 men developed prostate cancer, 17 white men, 7 black men and
4 high SES black men. These rates were in agreement with the expected number of cancers
from the national statistics for the same time frame (NCI, 1995).

Table 37
Incident Cases of Cancer Validated after 1974/75
Among Those with DDT-DDE Measurements
All Cancers

Breast

Prostate

White Men

60

0

17

White Women

54

18

0

Black Men

21

0

7

Black Women

12

3

0

High SES Black Men

11

0

4

158

21

28

Total
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All 21 women who developed breast cancer and all 28 men who developed prostate cancer
were selected as cases and matched by age and gender to four cohort members who had not
developed cancer. These 217 subjects comprise the group analyzed for this specific aim.

Mean levels of DDE
The mean serum levels ofDDE in 1974/75 for those men who developed prostate
cancer over the twenty-year period compared to their controls was 33.8 vs 41.4 ppb. The
mean level for women who developed breast cancer over the twenty-year period compared to
their controls was 26.7 vs 35.1 ppb.. Those who developed breast or prostate cancer
averaged lower serum levels ofDDE in 1974 than their cancer free controls. The differences
were statistically significant for both men and women using matched analysis.

Confounding
To investigate the potential existence of confounding variables, univariate descriptive
statistics for selected variables were examined across the exposure levels obtained for those
with cancer and their controls. Logistic and linear regression models were constructed with
DDE levels included as an ordinal variable to determine the presence of a linear trend.
Analysis was done for men and women separately. Table 38 contains the comparison of
putative risk factors across DDE tertile levels for the men. DDE levels decreased with
educational attainment, while there was no trend across DDE levels for age, race and
cholesterol. There was a suggestive association of smoking and higher BMI levels with
increasing levels ofDDE. The p-value for trend in both variables was only marginally
significant (p=O.08).
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Table 38
Comparison of Putative Risk Factors by Serum DDE Tertiles for Men
DDE Tertiles

I Tertile 1
Age (mean, years)
Race (% White)
Smoking (0/0 yes)
Cholesterol (mean, mg/dl)
Education (mean, years)
BMI (mean, kgIml)

n=43
59.4
67.4

27.9
238.7
11.3

25.3

Tertile2

Tertile3

n=47
61.2
66.0
36.2

0=50
59.0
50.0
46.0

231.9

233.4
9.1

9.8
26.7

27.1

p-value *
0.80
0.20
0.07
0.56
0.03
0.08

* Logistic and linear regression models were used to test linear trend
Table 39 contains the results of similar analyses for women. Increasing levels of
DDE with age and higher levels in blacks compared to whites were noted for the women. No
statistically significant trends were seen for smoking, cholesterol, education or BMI. A
number of breast cancer risk factors were also examined to detennine any association with
serum DDE levels in women. A decrease in the percent who reported a positive lactation
history across increasing DDE tertiles was seen, but this was not statistically significant
(p=O.41). There was a suggestive trend of the percent reporting a positive family history of
breast cancer.

Th~

trend, however, was in a negative direction, indicating lower DDE levels

were associated with an increased probability of positive family history for breast cancer.
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Table 39
Comparison of Putative Risk Factors by Serum DDE Tertiles for Women
DDE Tertiles

Age (mean, years)
Race (0/0 White)
Smoking (0/0 yes)
Cholesterol (mean, mgldl)
Education (mean, years)
BMI (mean, kg/ml)
Nulliparous (0/0 yes)
Lactation (% yes)
Family history breast cancer (%,yes)
Late age 1st full term pregnancy (% > 30)

Tertile

Tertile

1

2

n 38
56.2
94.7
26.3
249.0
10.7
25.7
18.4
55.3
26.3
4.0

n-34
58.0
94.1
14.7
250.2
11.1
26.0

8.8
50.0
15.6
19.2

Tertile
3
n=33
59.6
66.7
12.1
261.1
9.6
25.4
21.2
45.5
9.4
8.7

p-value*
0.05
0.01
0.12
0.29
0.10
0.85
0.79
0.41
0.07
0.57

*Logistic and linear regression models were used to test linear trend

These potential covariates were also tested to determine if they were associated with
an increased risk for cancer in the CHS cohort. After consideration of the matching criteria,
several putative risk variables were associated with prostate cancer for the men. As shown
in Table 40, those men with higher education and who were non-smokers were at a higher
risk for prostate cancer. No other variables were found to be significant risk factors either in
the unmatched or the matched analysis.
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Table 40
Selected Characteristics of Prostate Cancer Case Patients and Controls

Variable

p-valuea

Cases
(0 28)

Controls

Age at 1974/75 exam

60.3

59.7

0.74

Race (% white)

60.7

60.7

1.00

Education (mean, years)

10.6

9.9

0.43

0.05

BM! (mean, kg/m2)

25.6

26.6

0.33

0.10

Cholesterol (mean, mg/dl)

270.0

275.7

0.41

0.13

Smoking (%, current)

32.l

38.4

0.62

0.02

a

b

(0=112)

matched
p-valueb

p-value derived from pooled t-test or chi-square analysis
p-value derived from matched analysis, matched on age and race

Table 41 shows the results for women and breast cancer. A higher body mass index,
higher cholesterol level and negative lactation history were found to be risk factors for breast
cancer in the cohort. There was little difference in the other risk factors between the cases and
controls.

In summary, few variables were identified as confounders. Among the men, the only
variable tb~-tt was significantly associated (at the 0.05 level) with D[JE levels and also a risk
for prostate cancer was education. Among the women, there were no iaentifiable
confounding variables.
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Table 41
Selected Characteristics of Breast Cancer Case Patients and Controls

Variable
Age at 1974/75 exam
Race (% white)
Education (mean, years)
BMI (mean, kg/m2)
Cholesterol (mean, mg/dl)
Smoking (%, current)
Nulliparous (% yes)
Lactation (%)
yes
no
unknown
History of Breast Cancer (%)
yes+
no
unknown
Age at first full tenn pregnancy(%)
> = age 30 years
< age 30 years
unknown

matched
p-valueb

Case
(0-21)

Control
(n=84)

p-value

57.7
85.7
10.6
27.2
257.0
19.0
19.0

57.9
85.7
10.5
25.3
242.2
17.8
15.5

0.90
1.00
0.87
0.11
0.05
0.90
0.69

0.79
0.01
0.01
0.15
0.25

28.6
38.1
33.3

55.9
17.9
26.2

0.01

0.01

23.8
66.7
9.5

15.5
79.7
4.8

0.31

0.35

4.8
61.9
33.3

8.3
63.1
28.6

0.62

0.l7

a

p-value derived from pooled t-test or chi-square analysis
b p-value derived from matched analysis, matched on age and race
+ history = yes if mother, sister or daughter had breast cancer
a

Categorical Analyses ofDDE and Cancer
The results presented in Table 42 give the relative risk for prostate cancer incidence
associated with DDE levels categorized into tertiles. The analysis for the men yielded an OR
of 1.28 for those in the second tertile compared to the first and an OR of 0.60 for those in the
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third tertile compared to those in the first. The p-value for trend was not significant,
indicating no increased risk of prostate cancer associated with increasing levels of DDE. A
second model which adjusted for other risk variables including education, BMI, cholesterol
and smoking, showed a slight increase in risk for those in the second tertile. Although, the
estimates from this model were increased from the first; they still yielded a non-statistically
significant trend.

Table 42
Estimated Relative Risks for Prostate Cancer Incidence
ODE
Tertiles
1
2

3

cases

personyears

9
12
7

728
685
774

ORa (95% el)
1.00
1.28 (0.49, 3.34)
0.60 (0.20, 1.78)

ORb (95%CI)
1.00
1.42 (0.52, 3.90)
0.66 (0.21, 2.04)

Conditional logistic regression matched on age and race
b Matched on age and race; adjusted for smoking, education, BMI, cholesterol

a

The results for the relative risk of breast cancer associated with DDE levels in
women are presented in Table 43. There were 9 breast cancer cases in the lowest level of
DOE, 7 in the second tertile and 5 in the highest tertile. Results from the first model
indicated

::10

significant association between DDE levels and breast cancer incidence. The

second model, which adjusted for other putative risk factors, showed a further decrease in the
risk estimates compared to the first model, again indicating no association. Because the
confidence intervals were wide due to the small sample size and the large set of variables
included in the model, a stepwise regression was also implemented. This method indicated
no variables should be included.
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Table 43
Estimated Relative Risks for Breast Cancer Incidence
DDE
Tertiles

cases

personyears

1
2
3

9
7
5

706
618
559

ORa (95% CI)

ORc (95% CI)

1.00
0.84 (0.27, 2.64)
0.54 (0.15, 1.96)

1.00
0.48 (0.02, 9.89)
0.10 (0.01, 2.40)

Conditional logistic regression matched on age and race
C Matched on age and race; adjusted for smoking, education, BMI, cholesterol, lactation, history,
nulliparous, and age at first full term pregnancy
a

Non-Categorical Analyses ofDDE and Cancer
The results from the analyses using DDE level as a continuous risk factor for breast
cancer in women and prostate cancer in men are presented in Table 44. Both of the odds
ratios were very close to 1 indicating no statistical difference in risk across levels of DDE.
Since the 95% confidence intervals included 1.0, there was no evidence of a statistically
significant difference in risk for either breast or prostate cancer associated with increasing
levels of DDE. Models adjusting for additional covariates made only slight modification in
the estimates.
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Table 44
Estimated Relative Risks Matched on Age and Race
DDE as a Continuous Variable
cases

OR (95% CI)*

Men
ODE

28

0.975 (0.940, 1.011)

DDE

21

0.988 (0.969, 1.007)

Women

* OR derived from conditional logistic regression

Other analyses considered linear, quadratic and cubic terms for DDE levels to
investigate a possible curvilinear relationship between DDE levels and breast or prostate
cancer incidence. These results are shown in Table 45. Polynomial regression models also
showed no significant association. It was interesting to note that the sign for many of the
coefficients was negative. This added further evidence in support of the lack of an increased
risk for higher DOE levels shown in the categorical models.
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Table 45
Conditional Logistic Regression Coefficients
for Association between DDT and Prostate and Breast Cancer

Cubic Model
Linear
Quadratic
Cubic
Quadratic Model
Linear
Quadratic
Linear Model
Linear

Men
Coefficient
p-value*

Women
Coefficient
p-value*

0.001081
0.000524
-0.000009

0.9567
0.3275
0.3940

·0.013299
-0.001126
·0.0000309

0.7359
0.3676
0.6333

·0.010605
·0.0000292

0.4156
0.8487

-0.029108
-0.001123

0.2252
0.3142

-0.012238

0.2192

·0.025419

0.1673

*p-value derived from polynomial conditional regression analyses

Meta-Analysis/or Breast Cancer
Because of the existence of a number of published articles regarding the association
of breast cancer and DDE, a meta-analysis was performed to determine a summary risk
estimate combining the data from all the investigations. These results found in Table 46 are
based upon an ext~nsion of an earlier meat-analysis by Adami et. Al (1995). The summary
ratio was computed as 0.98 (95 % CI = 0.91, 1.06). Thus, all studies considered together
suggest no increased risk of breast cancer attributable to DDE levels.
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Table 46
Summary Analysis of Case-Control Studies for Breast Cancer and DDE
Using the Mean Ratio as the Effect Measure
Authorl
Year of study

No. Casesl
No. Controls

Case
Mean

Control
Mean

Ratio

(95% el)

915

1.53 ppm

4.32 ppm

0.35 (0.18-0.70)

14/21

1.23 ppm

1.25 ppm

0.98 (0.68-1.43)

Mussalo-Rauhamaal1990 41/33

0.96 ppm

0.98 ppm

0.98 (0.68-1.42)

Falckl1992

20120

1877 ng/g

1174 nglg

1.60 (1.09-2.34)

Wolff/1993

58/171

11.0 nglmL

7.7 nglmL

1 4 3 (1.11-1.84)

DewaiUy/1994

18/17

1370.6 f.1g1kg 765.3 J.lglkg

1.79 (0.83-3.88)

Wassermanl1976
Unger/1984

Q

Krieger/1994

150/150

43.3 ppb

43.1 ppb

1.01 (0.88-1.14)

Hunter/1997

236/236

6.01 ppb

6.97 ppb

0.86 (0.74-1.00)

21/84

26.7 ppb

35.1 ppb

0.76 (0.57-1.01)

CHS/1997
Summary

0.98 (0.91-1.06)

v.

Discussion
In 1960, when the Charleston Heart Study (CHS) began, it's primary aim was to

identify risk factors for heart disease. Data on potential or known risk factors for other
diseases, including cancer, were not obtained. For example, alcohol consumption and
diet have been shown to be associated with some cancers (Westview Press, 1982).
Information pertaining to alcohol use was not collected in the CHS until the mid 1980's
and studying the relationship of diet and health has not been possible in this cohort.
While there was one attempt to obtain nutritional information from cohort members, it
was limited to only a subsample of the cohort at a follow-up examination in 1987/88.
Other environmental factors including pollution, use of certain consumer products,
radiation, behavioral and life style factors, as well as infection, have also been suggested
as risk factors for cancer (Westview press, 1982). These variables were not obtained in
the CHS and therefore could not be evaluated. Information regarding other suggested
environmental risk factors for cancer was collected. Tobacco history was collected at the
baseline examination and also at various follow-up examinations. Education, occupation
and place of residence for the first 20 years of life, as well as from ages 20-65 was
obtained at the baseline examination. Physical activity has been inversely linked with
several types of cancer and self-reported activity levels were collected from CHS
members in 1963. Limited information on the source of drinking water was also
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available as participants were asked to simply identify whether or not they used city or
well water. From the information on these limited environmental factors that were
available, we observed an increased risk of cancer mortality for men who reported their
occupation as non-farm laborers. There was also an increased risk of cancer death for
both men and women with a positive history of cigarette smoking. No other statistically
significant associations were demonstrated for environmental factors in this cohort.
In addition to the environmental data collected at baseline, information on
pesticide use and DDT exposure was obtained in 1974/75. These data represented the
unique potential to examine the association of DDE levels with cancer in a prospective
fashion. Serum measurements of ODE were made on 898 participants along with selfreported use of pesticides in general and DDT in particular.
Because information was gathered on reported use of pesticides, we were able to
examine the utility of relying on self-reported data. The serum DDE values which were
compared with self-reported data and showed a definite discrepancy. It was expected that
those with higher levels of serum DDE would report more frequent use of pesticides and
DDT than those with lower levels of DOE. However, this was not the case. The lack of
agreement between serum levels and DDT use may be explained b:,' the fact that exposure
occurred through diet in addition to, rather than through, handling pesticides. In this way
individuals were probably not aware of their exposure. Dependence on self-reported data
alone was found not to be the best approach for investigating any association with cancer.
The association of cancer mortality and serum DDT levels in the CHS has been
examined previously by Austin et al. (1989). The present study added 10 more years of
follow-up and the number of cancer deaths was doubled compared to that found in 1984.
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Although some of the statistical methodology was different, overall the results confinned
the earlier findings that there was no evidence of an increased risk of cancer mortality
associated with higher DDE levels.
A number of choices concerning the best statistical approach for examining the
relationship between DDE and cancer was considered. There did not appear to be a linear
relationship between the exposure levels and cancer risk. The negative quadratic
association that was found in the polynomial regression was consistent with the
categorical analysis using tertiles of DOE. A higher risk for those individuals in the
middle tertile and a lower risk for those in the upper tertile was observed. These results
were also confinned using two other approaches. Standardized mortality analysis which
used an external comparison group, and multivariable analysis which allowed for
adjustment of other risk factors, were used to describe the relationship between DDE and
cancer. Both methods confinned the lack of a significant risk of cancer mortality.
Furthennore, the results from the statistical analyses which were based on external
comparisons provided evidence that the negative results were not due to any bias
associated with selection of cohort membership.
The association of ODE levels with specific cancer mortality was evaluated. The
sites for these analyses were lung, digestive tract, lymphatic and leukemia, and honnonerelated. Lung, digestive tract, and lymphatic and leukemia have been shown to occur
with greater frequency among some occupational pesticide users. (See Appendix B).
Lung cancer was the most frequent cause of cancer death observed within the CHS
cohort. Although, there was a slight increased risk of lung cancer mortality across ODE
levels, it was not statistically significant. There were more digestive tract cancer deaths
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observed in persons in the middle tertile of DDE than in the lowest or highest tertile.
There were only 9 cases of leukemia and lymphatic cancers, and the analysis indicated no
increased cancer risk across DDE levels. There were 17 hormone-related cancers in the
CHS. Again, no significant association was found with increasing DDE levels. Because
of the recent public health interest in DDTIDDE exposure and breast cancer, a specific
aim was developed to evaluate the relationship ofDDE with incident cases ofhreast and
prostate cancer. There was no evidence of an increased risk for either breast or prostate
cancer with higher levels ofDDE.
Key and Revees had performed a summary ratio of the published case-control
studies ofhreast cancer using the summary ratios of the mean concentrations of DOE
between cases and controls (Key & Revees, 1994). They found a summary ratio of 1.11
(99% CI =0.97-1.26). Adami et aI. performed a similar summary analysis in which they
included additional data from Wasserman et ale and found the summary ratio to be 1.08
(95% CI = 0.98 - 1.19) (Adami et aI., 1995). In both of the analyses there was no
significant association between DOE and breast cancer.

.

The meta-analysis was repeated including the recently published data from the
Nurses' He:llth Study and those from the CHS cohort (Hunter et aI., 1997). The summary
ratio was 0.98 (95 % CI = 0.91, 1.06). This summary ratio decreased v/hen the additional
studies were included, reflecting the negative findings in both of the most recent
investigations.
The lack of positive findings was not surprising since the isomers of DDT with
estrogenic properties are very weak (Stone, 1994). The predominate metabolite,
p,p'DDE, is not estrogenic, hut has shown antiandrogenic activity in rats (Kelce, 1995).
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The o,p' isomer of DDT has been shown to be estrogenic in animal studies but is usually
below the detection limit in human samples (Safe, 1995).

Limitations
As noted earlier, we were unable to address many of the suggested cancer risk
factors such as alcohol consumption and diet. We were, however, able to examine
information on a number of the other putative risk factors which were collected years
before the onset of cancer. Although a significant association was observed for men who
reported their occupation as a laborer, detailed information onjob histories were not
available. Thus, the contribution of risk of occupation to cancer mortality was limited to
descriptive studies.
The results for many analyses were based on relatively small sample sizes.
However, with a sample of almost 900 there was over 80% power to detect a relative risk
of 1.40 or greater in the overall cancer mortality analysis (Hintze, 1996). Although small
effect sizes may not have been detectable, especially in reference to breast and prostate
cancer, there was sufficient power ( > 80 %) to detect the size of the risk reported by
others for breast cancer (Wolff, et aI., 1993). Because of the small sampl.;: size we were
unable to evaluate the relationship ofDDE with all site-specific cancers. Also because of
the small sample size we were not able to perform separate analysis for ethnic groups;
however, we were able to adjust for race in all of the analyses.
There may have been confounders for which we were unable to control, but for a
variable to be a confounder it must be associated with DDE levels and also be a risk
factor for cancer. After examining several variables that may have been confounders, age
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and gender were the only variables identified. After adjustment for these, as well as other
putative risk factors, there was no evidence of an increased risk of cancer associated with
the exposure to DDE. The relationship ofDDE levels to incident cases may be different
than to mortality, but our results on breast and prostate cancer incidence also suggested
no increased risk.

Strengths
This study has several strengths. The cohort had complete follow-up from 1974
through 1994, and ascertainment and classification of cause of death was done without
knowledge of the subjects' risk variables. The potential for recall bias was greatly
reduced, as was selection bias, given the prospective nature of the study. Because of the
excellent follow-up of our cohort, and the repeated examinations of this group, it is
unlikely that any cases of cancer were missed. Eighty-six percent of all the reported
cancers and 100% of the breast and prostate cancers were verified by pathology reports so
that misclassification errors were minimized.
The results were obtained from a prospective study in which serum samples of
DDE were Inade years before the cancer death or incidence, unlike previous studies that
have determined the serum level at the same time as the cancer diagnosis. The CHS was
not an occupationally exposed group; however, compared to a national survey, the cohort
had high levels of DDE. The median DOE level for the CHS was 31 ppb - a value much
higher than the median of 18.1 ppb in the U.S. population from 1976-1980 (Murphy &
Harvey, 1985).
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Conclusions
Although the number of subjects available was relatively small, the primary
strength of the study lies in the extended follow-up time that occurred after the exposure
assessment data was collected. Given the fairly long latency period associated with
cancer, sufficient time for follow-up of incidence and mortality is an important
consideration. The evidence from this prospective study thus makes a substantial
contribution to the literature related to DDT exposure and cancer. The findings of this
study suggest there is no increased risk of cancer mortality associated with increasing
levels ofDDE. For the women, there was no evidence of an increased risk of breast
cancer incidence; for the men there was no evidence of an increased risk of prostate
cancer incidence; and for all subjects there was no increased risk of cancer mortality.
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Appendix A
Identified Occupational Groups with Excess Risks for Cancer*

Occupational Group

Site(s)

Agricultural workers

Leukemia
Lip
Liver
Lung

Architects

Kidney

Artists

Various sites

Bakers

Lung

Benzoyl chloride manufacturers

Lung

Brewery workers

Various sites

Calcium Carbide manufacturers

Colon
Prostate

Cement workers

Lung
Stomach

Chemists or chemical workers

Brain
Breast
Cervix
Genitourinary
Large intestine
Lung
Lymphatic and hematopoietic
Ovary
Skin
Testis
None

Coal miners

Stomach
Leukemia
Lung
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Appendix A, continued

Occupational Group

Site(s)

Coke by-product plant workers

Colon
Pancreas

Dry cleaning and solvent-exposed workers

Bladder
Cervix
Kidney
Liver
Lung

Firefighters

Various sites

Glass manufacturers

Review

Hairdressers and barbers

Review

Lead workers

Various sites

Leather workers

Bladder

Meat workers

Hodgkin's disease
Lung

Nonionizing Radiation-exposed workers

Blood
Brain

Oil refinery/petro worker

Blood
Bone
Brain
Kidney
Lymphatic
Pancreas
Skin
None

Paint manufacturers

Liver
Lung
Bladder
Kidney
Myeloma
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Appendix A, continued
Occupational Group

Site(s)

Pesticide-exposed workers

Lung
Lymphatic
Skin
Reviews

Plumbers

Lung
Skin

Pulp and paper workers

VariollS sites

Rubber industry work areas

Bladder
Blood
Lung
Skin
Stomach

Steelmakers

Lung

Textile workers

Several sites

Truck drivers

Bladder

Veterinarians

Various sites

Waitpersons

Lung

Welders

Lung
Reviews

Woodworkers

Lymphatic tissue
Review

* Monson R.R. "Occupation." Cancer Epidemiology and Prevention, 2nd edition, edited by
D. Schottenfeld and J.F. Fraumeni. New York, Oxford Press University. 1996, pp. 418-436.

Appendix B
Summary of Studies Regarding DDT and Cancer
First Authorl
Year of
Publication

Study Design

Population

Adami/1995

Meta Analysis

AiavanjaJ1990

Occupational Study
Cohort mortality &
nested case-control
study
Occupational Study
Prospective cohort

AlavanjaJ1987
Alavanjal1987
Darthcll1987

Blair/1979

Occupational Study
Proportionate
Mortality
Occupational Study
Proportionate
mortality
Retrospective
cohort
Case control study

~--~

Summary study
regarding the studies
published to date on
breast & endometrial
cancer and DDT
US Grain Millers
(1955-1985)
22,938 white males

~

...

~

•.

".-~,-

- - - " _.... _----_

... _----

Site

DDT, PCB, TCDD

breast and
endometrial

Outcome

I
I

No association for either
cancer

Cohort analyzed all Excess risk for NHL,
cause death w/site leukemia and pancreatic
specific cancer
cancer.; also increase risk
for case-control study
Exposure to pesticides all cancer and site Increased risk for liver
cancer
specific
I
SIR = 238
exposure to pesticides all cancer and site Increased risk for
pancreatic (PMR 191) and
specific
lymphoma (PMR 272)
Increased risk lung cancer '
Fungicides,
all cancers and
(SMR2)
insecticides (DDT),
lung
herbicides, others
Chemicals used in
facility
Interviews

Swedish Grain millers
(1961-1979)
2,649 white males
US Grain millers
(1968-1983)
1,114 white males
German pesticide
sprayers
(1948-78)
1,658 male
Nebraska (1957-74)
white males
1,084 cases 2,168
controls

Exposure/
Type or Source

I

I

A death certificate
study
-~~

leukemia

OR=1.25 signficant

-

....0\

Blair/1983

Occupational Study
Retrospective
cohort

Blair/1991

Occupational
Meta Analysis

Blair/1995

Occupational
Meta Analysis

..

Bouwmanl1994

Bouwmanl1991

Uro \\/1111990

Malaria control
Longitudinal
prospective cohort
Occupational
Cross-sectional

Population
case-control

-

~.

Florida pesticide
applicators
( 1965-1977)
3,827 white male
Farmers
Over 20 cohort studies
and summary of casecontrol

South Africa men and
women
1986-1987
DDT appliers South
Africa
Malaria control
Black nlcn and \VOlllen
23 sprayers & matched
Iowa or Minnesota;
white men
(1981=84)
578 leukemia & 1245
matched

Pesticides used in
structural pest control
(included DDT)

all cancers and site
specific

Pesticides

all causes, cancers
and site specific

Farmers

all cancers and site
specific

Overall SMR not
significant; excess for
leukemia and brain and
lung
Overall not significant
increased; excess:
leukemia, NHL,
Hodgkin's, multiple
myeloma and lip, stomach
skin prostate brain testis
and connective tissue
elevated rates for
leukemia, NHL, multiple
myeloma, soft-tissue
sarcoma,
skin,lip,stomach,brain,
prostate
no additional risk from
1986 to 1987

DDT; blood samples

none

DDT;blood samples

none

DDT levels higher cases

Large agricultural
populations; risks
were calculated for
mix, handling
insecticides (DDT)

leukemia

OR=I.2 for fanners
compared to non; Slight
risk leukemia associated
with DDT

~
~

-.....l

!

I

!

Brownsonl1988

Occupational risk
cancer registry
based case-control

White male (1984-1986)
1239 prostate cancer
matched 3717 controls

Brownsonl1993

Occupational risk
Population based
case-control
Occupational study
Proportional
mortality
Occupational study
Case-control study

Missouri white women
(1986-1991 )
lung cancer
Iowa farmers
(1971-78)
6,402 white males
Farmers Iowa
(1964-78) white males
1,675 cases 3,350
controls
Farmers Iowa
(1964-78) white males
8,290 cancer cases
Iran 1991-1992
8 men & 53 female
Wisconsin farmers
(1968-76) white males
411 cases 725 controls
US Pesticide applicators
(1965-1979)
9,727 white male

Burmeister/1981

Burmeister/1982

Burmeister/] 983

Occupational study
Case-control study

Burgazl1995

Population exposed
Cross Sectional
Occupational study
Case-control study

Cantor/1984

Cantor/1991
--

Cantor/1992

Occupational study
Mortality cohort

Occupational risk
Population based
case control

Agricultural workers in
Iowa and Minnesota
(1980-83)
white males
622 NHL & 1245
matched

Missouri cancer
registry for
occupations with
exposure
Interviews obtained
occupational factors

prostate cancer

Increased risk of prostate
cancer among fanners

lung cancer

Pesticides, herbicide

all cancers and site
specific

Pesticides, herbicides

leukemia

elevated risk among
women exposed to
asbestos and pesticides
elevated stomach, skin,
prostate, lip, colon,
pancreas, leukemia
OR=I.24 signficantly
increased risk of leukemias
for farmers

Pesticides, herbicides

all cancers and site
specfic

DDT, DDE; adipose
tissue
A death certificate
study
Pesticides, herbicides
Pesticides

none

Pesticides; Interviews

multiple myeloma

all causes, cancers
and site specific

NHL

elevated muliple myeloma,
nonHodgkins lymphoma,
stomach, prostate
DDEIDDT increased from
1.91 to 11.82
OR=I.4; signficant
increase risk of myeloma
for farmers
SMR below expectation

Farmers increased NHL
OR= 1.2

"'"""'"
"'"""'"
00

i

CarlsonJ1978

Occupational study
Proportional
Mortality cohort

Coggonl1986

Occupational study
Proportionate
mortality
cohort
Descriptive study
Meta-Analysis

-

California agricultural
workers
(1959-1961)
3,844 white males
British pesticide sprayers
(1947-75)
9,677 white males

Farm laborers and
foremen compared to
farm managers

all causes, cancer
and site specific

PMR=131 ns

MCPA and other
pesticides

all cancer and site
specific

nasal

Davis/1992

Occupational
Meta-Analysis

Should DDT continue to
be used for malaria
control?
Farmers
20 studies in 8 countries

Delzell/1985

Occupational study
Proportionate
mortality

NC farmers
(1976-1978)
white and nonwhite

Farming listed as
occupation of death
certificate

all; cancer and site
specific

DeWailly/1994

Population
Hospital casecontrol
Exploratory
occupationa' study
using de"'i i·
certificates
Occupational risk
Population based
case control

Women (1991-1992)
20 breast cancer & 17
match
NC black southeastern
states

PCB, DDE; fat and
plasma

breast cancer

Sweden (1982 . . 1986)
239 myeloma &
matched control

Questionnaire
Multiple myleoma
regarding occupations
and specific chemicals
(DDT)

Curtis/1994

Dosemeci/1994

DDT

pancreatic and
breast

Meta anlaysis for these
cancers

21 broad occupational
surveys

cancer and sitespecific

Increased sites: melanoma,
prostate, NHL, multiple
myeloma, breast, brain,
kidney
PMR = 90 whites
significant;
PMR = 90 nonwhite ns
Both increased prostate
Women ER+ breast cancer
had higher levels DDE

prostate cancer

~,.'.L\l

Erikssonl1992

~-

...

,--

38%of excess prostate
cancer mortality may be
associated with farming
Association found among
farmers and myleoma
I

......
......
-..0

Falckl1992

Fasal/1968

Frank/1988

Gallagher/1984

Population
Hospital casecontrol
Occupational study
Proportionate
mortality
Population
Cross Sectional

Occupational study
proportionate
mortality

Garabrantl1992

Occupational risk
nested case-control

Garry/1994

Occupational study
cross-sectional
survey
proportionate
mortality
Occupational study
Prospective cohort

Hansen/1992

Holsen/1988

Occupational study
Retrospective

Women white (1987)
20 breast cancer&20
benign
Farmers in California
(1959-1961)
1,857 white males
Ontario Residents, 19761985
570 adipose sample; 348
milk; 118 blood
British Columbia farm
workers
(1950-78)
2,328 male
Chemical manufacturing
workers (1948-1971)
white & non white males
28 pancreatic & 112
matched
Minnesota pesticide
appliers
719 random selected
males

DDT,DDE,PCB,PBB,
BHC,HCB,Deildrin,
Cholrdane;fat
Pesticides

breast cancer

Elevated levels DDT in fat
women with breast cancer

leukemias and
lymphomas

nonsignficant elevated
ratios

DDT, PCBs,
HCB,dieldrin,mirex;
fat, milk, blood
samples
Canadian
occupational manual
format from vital
records
DDT

none

DDT declined 1970s to
1980s

all, cancer and site
specific

PMR 78 ns for all cancers
stomach cancer increased

pancreatic cancer

OR=4.8

chronic disease

Chronic disease increased
in fumigant appliers

Herbicides,
insecticides,
fumigants and
fungicides

Insecticides,
cancer and site
herbicides, fungicides, specific
disinfectants,
fertilizers
Denmark Cancer registry Employment histories sinonasal cancer
1970-1984
in registry

Danish gardeners
(1975-1984)
4,015 males and females

males significant increase
soft tissue sarcoma,
lymphatic leukemia, NHL
Below expectation

cohort

~

N

o

I

Hooly/1992

Hovinga/1993

Parental Occupation
risk
case control study
-_......._.
Environmental
exposed
Prospective cohort

Kashyap/1993

population exposed
cross-sectional

Kashyap/1994

population exposed
Cross Sectional

Keil/1973

Population

Key/1994

Meta-Analysis

Kreiger/1994

Population
Nested case-control
Incidence

Mothers 43 Ewing's
bone sarcoma patients
(1978-1986) & 193
controls in CA
Great Lake fisheaters
(1982-1989)
male and female white
115 fish and 95 nonfish
eaters
India
male and female
21 fat tissue & 20 blood
India food intake
male and female
20 duplicate diet
samples
GAand SC
black and white
6 studies regarding DDT
and breast cancer
N.CA Region Kaiser
Permanente Medical
Care Prgm
white,black,asian
women
150 breast & 150 match

Interview on
occupational hx

Ewing's bone
sarcoma

Lead, Cadmium, PCB, none
and DDT; blood
samples

elevated risk for children
whose fathers exposed to
herbicides, pesticides or
fertilizers
Elevated PCB and DDT
levels observed for fish
eaters

DDT and HCH; fat
and blood samples

none

males had higher residues
than females

DDT and BCR; food
and blood samples

none

Blood DDT levels
reflected food intake

DDT; blood

none

DDT,DDE,PCB;
blood, fat
DDE,PCB; blood

breast cancer

blacks higher DDT then
whites
Summary DDE 1.11
(99%CI: 0.97-1.26)
no association; there is an
association for white and
black

breast cancer

~

N
~

Kreiss/1981

Population exposed
cross-sectional

Littorinl1993

Occupational study
Retrospective
cohort
Mortality and
morbidity
Populational study
Descriptive and
summary study

LopezCarrillo/1996

Ludwicki/1994

Population
Cross Sectional

Mabuchi/1980

Occupational study
Mortality cohort

Morrisonl1992

Occupational study
Mortality cohort

Morrisonl1995

Occupational study
Retrospecti ve
mortality cohort

Triana,AL downstream
defunct DDT plant in
1979
males and females adults
and children
Swedish market
gardeners
(1965 .. 1982)
2370 horticulturists'
association
Public health impact in
Mexico during the last
20 years
Poland 1989-1992
277 men and women
age 10 - 80
Pesticide Manufacturing
workers in Maryland
(1946-74)
3,141 white/non,
male/female
Canadian prairie farmers
(1971-1987)
156,242 male farmers
Canadian farmers
(1971-1987)
145,383 male over 45
yrs

DDT;blood

none

DDE accounted for an avg
of 86.7% of total DDT

Fungicides and
Insecticides

all cancers

SMR = 90 ns for all
cancers

DDT and DDE

none; Analysis of
studies with levels
in blood, fat and
milk
none

Compares levels in Mexico
and the US

DDT, DDE, HCH,
HCB, PCB; adipose
tissue
DDT, chlordecone,
Aldrin, arsenate,
organophosphates,
herbicides
Exposure indices from
1971 Census
Agricultural records
Herbicides,
insecticides,
fertilizers, other

DDE highest
concentration; age factor

all cancers and site
specific

lung

all and brain
cancer

SMR = 77 ns for all cancer

prostate cancer

Association between
number of acres sprayed
with herbicides and risk of
prostate cancer mortality

~

N

N

Moysichl1997

Populational study
case-control study

postmenopausal women
154 cases; 192 controls

Serum levels of DOE

breast cancer

Murphy/1985

Population Survey
Cross Sectional

NHANES II, 12-74 yrs
from 64 locations across
US
Finland (1985-1986)
women
44 breast & 33 controls
Florida pesticide appliers
(1965-1982)
4,441 white and black;
male and female
1975 and 1985 blood

DDT, DDE; blood

none

DDT,DDE,HCH,DD
D,PCB,HCB; adipose
tissue
Carbamates,
organophosphates,
phenoxyacetic acids
and DDT
DDT, ODE, DDD

breast cancer

no association

all cancer; lung
cancer

SMR = 140 all cancers;
OR 2.1 for lung cancer
licensed over 20 years

none

Lower levels in 1975 than
in 1985
DDT levels 20 to 30 times
higher in cases.
no difference between farm
& other occupations

Population
MussaloRauhammal1990 Hospital casecontrol
Occupational study
Pesatori/1994
Prospective cohort
&
nested case-control
Population
Pines/1987
Longitudinal Study
Occupational study
Polandl1970
Rappoltl1970

Occupational risk
Cross Sectional

Riihimaki/1982

Occupational study
Mortality study

RiveroRodriguezl1997
-

Occupatinal study
Cross sectional
study
--

OR=1.49(O.73,3.04)
No association DDE and
postmenopausal breast
cancer
Median DDE level 18.3
ppb

I

DDT Factory workers
Kern County, CA
male and female; white,
black, Spanish; autopsy
material
Finnish sprayers
(1955-71)
1,926 Finnish men
Spraying DDT to control
malaria in Mexico
371 sprayers with over
20 years on the job
- -

DDT; serum and
adipose tissue
Pesticide input is the
third highest per area
in the world;
fat, placenta, cords
Dichlorophenoxy
acetic acid, herbicid;'~

none
none

all cancers

I

none
!

I
I

DDT and DDE

none; measured
mean levels in
adipose tissue and
J?y questionnaire

High levels found; derived
an index of chronic
occupational exposure

I

I

I

I

......

tv

w

Rogan/1987

Population Mothers
Prospective birth
cohort

Ronco/1992

Occupational study
Prospective cohort

Saftlas/1987

Occupational study
Mortality study

Shindell/1986

Occupational study
Prospective
mortality

Spicer/1993

Population Mothers
Cross Sectional
Population Mothers
Cohort Study

Stevens/1993

Sturgeonl1997

Stubbs/1984
-

-----

.

-~~-

Populational study
PopuhHh;U casecontrol
Occupational study
Mortality study
'-----

North Carolia Breast
Milk & Formula Project
enrolled 1978-82; 858
children from birth to
lyr
Danish and Italian
Farmers
1970-1980
Males and females; 1575 yrs old from cancer
registry
Wisconsin farmers
(1968-76)
35,972 white males
Chlordane factory
workers
( 1946-1985)
800 white,black,
male,female
New Guinea Lactating
mothers 1990
Australian Nursing
mothers
white women
women
(1987-1990)
97 cases 97 controls
California agricultural
workers (1978-79)
7,504 white/non males

DDT, DDE; blood,
cord, placenta, milk

none

High levels ofDDE
associated with shorter
lactation

Occupational census
data

all cancers and site
specific

Reduced risk of lung,
bladder, small intestine,
colon, rectum and prostate

I

I

pesticides

all cancers, site
specific

stomach, prostate,
leukemia, eye, lymphoma

chlorodane

all cancers

SMR87

DDT; milk

none

DDT, HCB, Dieldrin

none

100% of mothers had DDT
in their milk
A fall in level of Ocs was
noted since 1974 survey

measured serum DDE
levels; large
multicenter trail
pesticides

endometrial cancer

all cancers, site
specific

Quartne~

1.0, 0.85, 1.1, 1.1
no association DDE and
endometrial cancer
stomach (white); brain
(non)
._-

........

tv

~

Populational study
Case-control study
Population
Hospital casecontrol

51 cancer cases from
autopsy and controls
Women : cases 14 breast
patient, 18 breast
deceased;
controls 21 noncancer
patient, 35 noncancer
deceased

DDT and PCB;
adipose
DDT, PCB; adipose
tissue

Van der
Gludenl1996

Occupational
Meta Analysis

Farmers

prostate

excess risk of prostate
cancer

Wangl1979

Occupational study
Prospective cohort

Case-control studies,
cohort studies & death
certificate
Nationwide pesticide
appliers
(1967-1976)
16,126 white males

all cancers and site
specific

SMR 83 all cancer ns
Bladder cancer was in
excess

Wassermann!
1976

population
Hospital casecontrol
Mortality
Population
Correlationa1 ~tHdy
Mortality

Fumigants, botanicals,
carbamates,
chlorinated
hydrocarbons,
organophosphates,chl
ordane,heptachlor
DDT; malignant and
adjacent adipose
tissue

breast cancer

increase in DDT compared
to adjacent tissue

breast cancer

breast cancer mortality rate
double than other countries
with comparable levels of
fat consumption

Unger/1982
Unger/1984

Westonl1990

women; Camargo
Hospital
9 breast and 5 controls
Autopsy material
Women in Israeli 19761986

All cancers
breast cancer

Correlation found between
cancer and DDT in fat
no association

,

i

Pesticide residues in
cows; DDE,Lindane,
BHC

I--"

N

V'I

Wigle/1990

Occupational Study
Mortality cohort

Canadian farm operators
(1971-1985)
70,000 male farmers

Wiklund/1989

Occupational study
Prospective cohort

Wiklund/1986

Occupational study
Retrospective
cohort

Wolff/1993

Population
Case-control/cross
sectional

Swedish pesticide
appliers
(1965-1982)
20,245 male and female
Swedish agricultural
workers
(1961-1979)
254,417 men cancer
registry
Women NY University
Health Study (19851991)
58 breast & 171 match
Chemical workers
manufacturing plants
(1935-1976)
3,579 US white men
21 farm studies

Occupational study
Historical
prospective
mortality study
Occupational
Meta Analy_sis
Occupational
Meta Analysis

Wongl1984

Zahml1992
Zahml1993
..

-_ ...__ . _ - - - - - - _.• -

--

-

Farmworkers in US and
Canada

1971 Census of
agriculture;
Herbicides and
insecticides
Pesticides

all causes; all
cancers and NHL

no excess risk

all cancers

significant decreased risk

Cancer Environment
Registry

all cancers and site
specific

RR=0.82

DOE, PCB; blood

breast cancer

4 fold increase risk of
breast cancer for high
levels of ODE

i

I

I

i

DDT, DBCP, TRIS,
PBB

all cancer and lung
cancer

SMR 95 ns all cancer for
specific DDT e~posure
listed

pesticides

NHLonly

excess NHL

pesticides

all cancers and site
specific

Describes a few studies
that have been done on
cancer

._-

~

N

0\
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Appendix C
SMR of Cancer Deaths for Charleston Heart Study
by Age and Calendar Year
Age

Calendar

Year

1974-79

1980-84

1985-1989

1990-1994

TOTAL

obs death
person years

0
53.96

0

0

0
0

0
0

0
53.96

N

9

°

0
0
0

0
0
0

0

0.031

0
0
0

4
1622.20
278
246.58
2.91

0
169.08
34
0
0.30

0
44.97
9
0
0.07

4.97
1
0
0.007

obs death
person years
N
rate* 100,000
expected
SMR

7
2023.33
350
345.96
8.69

4
1712.38
354
233.59
7.57

4
1191.86
248
335.61
5.39

2
265.85
55
752.301
1.17

17
5193.42

obs death
person years

15
1201.19
216
1248.76
9.40

14
1320.02
288
1060.59
10.91

18
1280.15
281
1456.08
10.96

8
1441.94
304
554.808
12.6

55
5243.30

4
233.53
43
1712.84
2.90

5
435.25
99
1148,76
5.41

4
591.66
135
676.07
7.65

15
721.07
178
2080.24
9.79

28
1981.51

0
11.99
2

71.81
18

°
°
1.29

4
136.94
41
2920.90
2.44

4
298.73

26
3186.57
698
851.92
25.36
1.02

29
2570.76
579
1128.07
26.01
1.11

1974n5

35-44

rate* 100,000
expected
SMR
45-54

obs death
person years
N

rate * 100,000
expected
SMR
55-64

65...74

N

rate* 100,000
expected
SMR
75-84

obs death
f'ers.on years
N
·t~e* :t 00,000

e;{rected
SMR
>85

obs death
person years
rate* 100,000
expected
SMR

0.19

°

°
°
1.15

obs death
person years
N
rate* 100,000
expected
SMR

30
5146.20
898
582.95
24.21
1.24

23
3708.60
793
620.18
25.34
0.91

N

TOTAL

77.93
25

°

0.031
0
4
1841.22
246.58
3.287
1.22

327.34
22.82
0.74

1048.95
43.87
1.25

1413.09
25.75
1.09

1338.98
5.07
0.19
108
14612.13
739.11
100.83
1.01
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AppendixD
SMR for Cancer Death Rate by DDE Tertiles, Calendar year and Age

Stratum
Year, Age
1974-1979
35-44

DDE

observed
person-year
expected

1

2

Tertile
3

0
11.99
0.007

0
11.99
0.007

0
29.98
0.017

0
53.96
0.031
0

3
629.05
1.13

0
538.26
0.967

1
454.88
0.817

4
1622.19
2.91
1.37

2
681.766
2.93

1
695.11
2.98

4
646.45
2.77

7
2023.33
8.68
0.81

3
402.809
3.15

6
381.582
2.98

6
416.80
3.26

1
78.398
0.97

1
53.79
0.67

2
101.34
1.26

15
1201.19
9.44
1.59
4
233.53
2.9
1.38

0
5.99
0.096

0
0
0

0
5.99
0.096

9
1810.0
8.28
1.09

8
1680.7
7.60
1.05

13
1655.44
8.22
1.58

SMR
45-54

observed
person-year
expected

SMR
55-64

observed
person-year
expected

SMR
65-74

observed
person-year
expected

SMR
75-84

observed
person-year
expected

SMR
>84

observed
person-year
expected

SMR
Total

observed
person-year
expected

SMR

TOTAL

0
11.98
0.19
0
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Stratum
Year, Age
1980-84
35-44

observed
person-year
expected

Tertile

1

DDE
2

3

TOTAL

0

0

0

0
0

0
0

0
0
0

0
29.99
0.05

0
59.99
0.11

0
79.09
0.14

0
169.07
0.30
0

2
721.25
3.19

2
550.57
2.43

0
440.55
1.95

4
1712.37
7.57
0.52

1
425.63
3.52

8
410.14
3.39

5
484.25
4.00

14
1320.02
10.91
1.28

5
152.55
1.89

5
146.68
1.82

1
136.02
1.69

11
435.25
5.4
2.04

0
31.573
0.506

0
15.0
0.24

0
25.29
0.405

0
71.86
1.15
0

8

15

6

9.16
0.87

7.99
1.88

8.18
0.73

SMR
45-54

observed
person·year
expected

SMR
55-64

observed
person-year
expected

SMR
65-74

observed
person-year
expected

SMR
75-84

observed
person-year
expected

SMR
>84

observed
person-year
expected

SMR
Total

observed
person-year
expected

SMR

0
0
0
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Stratum
Year, Age
1984-1989
35-44

DDE
observed
person-year
expected

1

2

Tertile
3

0

0
0
0

0
0
0

0
0
0
0

0

0

0
0

SMR
45-54

observed
person-year
expected

0
9.99
0.016

9.99
0.016

0
24.98
0.04

0
482.45
2.18

1
391.06
1.77

3
318.34
1.44

4
1191.85
5.39
0.74

6
474.015
4.06

8
397.80
3.41

4
408.934
3.5

18
1280.75
10.97
1.64

2
215.206
2.78

2
149.645
1.93

0
226.806
2.93

4
591.66
7.64
0.52

0
33.601
0.56

0
21.26
0.35

0
23.07
0.38

0
77.93
1.29
0

8

11

7

9.74
0.82

7.48
1.47

8.29
0.84

SMR
55-64

observed
person-year
expected

SMR
65-74

observed
person-year
expected

SMR
75-84

observed
person-year
expected

SMR
>84

observed
person-year
expected

SMR
Total

observed
person-year
expected

SMR

TOTAL

44.96
0.07
0
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DDE

Stratum
Year, Age
1990-1994

1

2

Tertile
3

TOTAL

35-44

observed
person-year
expected
SMR

0
0
0

0
0
0

0
0
0

0
0
0
0

45-54

observed
person-year
expected
SMR

0
5.0
0.007

0
0
0

0
0
0

0
5.0
0.007
0

55-64

observed
person-year
expected
SMR

0
79.94
0.351

0
104.93
0.46

2
80.98
0.355

2
265.85
1.17
1.71

65-74

observed
person-year
expected

3
602.53
5.26

4
463.66
4.05

1
375.74
3.28

8
1441.93
12.59
0.63

SMR
75-84

observed
person-year
expected
SMR

7
232.526
3.16

4
180.843
2.45

4
307.658
4.17

15
721.03
9.78
1.53

>84

observed
person-year
expected
SMR

3
69.476
1.15

1
31.19
0.56

0
36.27
0.65

4
136.936
2.45
1.63

Total

observed
person-year
expected

13

9

7

9.93
1.31

7.52
1.20

8.45
0.83

34
5375.73
36.963
0.936

41
4613.49
30.64
1.34

33
4623.415
33.15
0.997

SMR
Overall
TOTAL

observed
person-year
expected

SMR

108
14612.64
100.75
1.07
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